<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="brca1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">brca1</book-part-id>
      <title-group>
        <title><italic toggle="yes">BRCA1-</italic> and <italic toggle="yes">BRCA2</italic>-Associated Hereditary Breast and Ovarian Cancer</title>
        <alt-title alt-title-type="alt-title">Synonym: HBOC</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Petrucelli</surname>
            <given-names>Nancie</given-names>
          </name>
          <degrees>MS</degrees>
          <aff>Wayne State University School of Medicine/Detroit Medical Center <break/>Karmanos Cancer Institute, Cancer Genetic Counseling Service <break/>Detroit, Michigan</aff>
          <email>petrucel@karmanos.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Daly</surname>
            <given-names>Mary B</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Chair, Department of Clinical Genetics<break/>Fox Chase Cancer Center <break/>Philadelphia, Pennsylvania</aff>
          <email>mb_daly@fccc.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pal</surname>
            <given-names>Tuya</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Moffitt Cancer Center<break/>Tampa, Florida</aff>
          <email>tuya.pal@moffitt.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>4</day>
          <month>9</month>
          <year>1998</year>
        </date>
        <date date-type="updated">
          <day>15</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>5</day>
          <month>12</month>
          <year>2005</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="bap1-tpds" document-type="chapter">
<italic toggle="yes">BAP1</italic> Tumor Predisposition Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="spg17" document-type="chapter"><italic toggle="yes">BSCL2</italic>-Related Neurologic Disorders/Seipinopathy</related-object>
      <abstract id="brca1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">BRCA1-</italic> and <italic toggle="yes">BRCA2-</italic>associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a <italic toggle="yes">BRCA2</italic> pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant<italic toggle="yes">.</italic></p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> HBOC is established in a proband by identification of a heterozygous germline pathogenic variant in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> National Comprehensive Cancer Network guidelines suggest that women with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant could consider bilateral mastectomy as a primary surgical treatment of breast cancer because of their elevated rate of ipsilateral and contralateral breast cancer. Treatment of ovarian and other cancers in individuals with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant is similar to that for sporadic cancers.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Prophylactic bilateral mastectomy, prophylactic oophorectomy, and chemoprevention (e.g., tamoxifen) have been used for breast cancer prevention, but have not been assessed by randomized trials in high-risk women. Prophylactic oophorectomy for ovarian cancer prevention.</p>
          <p><italic toggle="yes">Surveillance:</italic> Breast cancer screening in women relies on a combination of monthly breast self-examination, annual or semiannual clinical breast examination, annual mammography, and breast MRI. Annual transvaginal ultrasound and CA-125 concentration beginning at age 35 years may be considered for ovarian cancer screening. However, this screening has not been effective in detecting early-stage ovarian cancer, either in high-risk or average-risk women. For men, breast cancer screening includes breast self-examination education and training and annual clinical breast examination beginning at age 35. Annual prostate cancer screening should begin at age 45. Screening for melanoma should be individualized based on the family history. Screening of asymptomatic individuals for pancreatic cancer is not generally recommended.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Once a cancer-predisposing <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant has been identified in a family, testing of at-risk relatives can identify those family members who also have the familial pathogenic variant and thus need increased surveillance and early intervention when a cancer is identified.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Germline pathogenic variants in <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> are inherited in an autosomal dominant manner. The vast majority of individuals with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant have inherited it from a parent. However, because of incomplete penetrance, variable age of cancer development, cancer risk reduction resulting from prophylactic surgery, or early death, not all individuals with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant have a parent affected with cancer.</p>
          <p>Offspring of an individual with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant have a 50% chance of inheriting the variant. Prenatal testing is possible for pregnancies at increased risk if the cancer-predisposing variant in the family is known; however, requests for prenatal diagnosis of adult-onset diseases are uncommon and require careful genetic counseling.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="brca1.Diagnosis">
        <title>Diagnosis</title>
        <sec id="brca1.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">BRCA1-</italic> and <italic toggle="yes">BRCA2</italic>-associated hereditary breast and ovarian cancer (HBOC) <bold>should be suspected</bold> in individuals with a personal or family history (1<sup>st</sup>-, 2<sup>nd</sup>-, or 3<sup>rd</sup>-degree relative in either lineage) of any of the following characteristics (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp">NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian</ext-link> &#x02013; registration required):</p>
          <list list-type="bullet">
            <list-item>
              <p>Breast cancer diagnosed at or before age 50 years</p>
            </list-item>
            <list-item>
              <p>Ovarian cancer</p>
            </list-item>
            <list-item>
              <p>Multiple primary breast cancers either in one or both breasts</p>
            </list-item>
            <list-item>
              <p>Male breast cancer</p>
            </list-item>
            <list-item>
              <p>Triple-negative (estrogen receptor-negative, progesterone receptor-negative, and HER2/neu [human epidermal growth factor receptor 2]-negative) breast cancer, particularly when diagnosed before age 60 years</p>
            </list-item>
            <list-item>
              <p>The combination of pancreatic cancer and/or prostate cancer (Gleason score &#x02265;7) with breast cancer, and/or ovarian cancer</p>
            </list-item>
            <list-item>
              <p>Breast cancer diagnosed at any age in an individual of Ashkenazi Jewish ancestry</p>
            </list-item>
            <list-item>
              <p>Two or more relatives with breast cancer, one under age 50</p>
            </list-item>
            <list-item>
              <p>Three or more relatives with breast cancer at any age</p>
            </list-item>
            <list-item>
              <p>A previously identified <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant in the family</p>
            </list-item>
          </list>
          <p>Notes: (1) "Breast cancer" includes both invasive cancer and ductal carcinoma in situ (DCIS). (2) "Ovarian cancer" includes epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.</p>
          <sec id="brca1.Probability_Models_for_BRCA12_Path">
            <title>Probability Models for <italic toggle="yes">BRCA1/2</italic> Pathogenic Variants</title>
            <p>Several models have been developed to estimate the likelihood that an individual or family has a germline pathogenic variant in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> [<xref ref-type="bibr" rid="brca1.REF.parmigiani.1998.145">Parmigiani et al 1998</xref>, <xref ref-type="bibr" rid="brca1.REF.frank.2002.1480">Frank et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.antoniou.2004.1580">Antoniou et al 2004</xref>, <xref ref-type="bibr" rid="brca1.REF.evans.2004.474">Evans et al 2004</xref>, <xref ref-type="bibr" rid="brca1.REF.tyrer.2004.1111">Tyrer et al 2004</xref>]. According to the American Society of Clinical Oncology (ASCO) policy statement on genetic testing for cancer susceptibility [<xref ref-type="bibr" rid="brca1.REF.american_society_of_clinical_oncology.2003.2397">American Society of Clinical Oncology 2003</xref>], there is no numeric threshold generated from these models that should be used in determining the appropriateness of genetic testing. The use of probability models, however, has been shown to help further discriminate which individuals are more likely to have a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant, even among experienced providers [<xref ref-type="bibr" rid="brca1.REF.euhus.2002.844">Euhus et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.de_la_hoya.2003.503">de la Hoya et al 2003</xref>]. For more information about probability models for <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="brca1-probability_models.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
          </sec>
        </sec>
        <sec id="brca1.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">BRCA1</italic>- and <italic toggle="yes">BRCA2</italic>-associated hereditary breast and ovarian cancer (HBOC) <bold>is established</bold> in a proband by identification of a heterozygous germline pathogenic variant in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> on molecular genetic testing (see <xref ref-type="table" rid="brca1.T.molecular_genetic_testing_used_i">Table 1</xref>).</p>
          <p>Note: (1) Molecular testing is most likely to be informative in an individual with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic>-associated cancer (e.g., breast cancer at age &#x0003c;50 years, ovarian cancer) and is often referred to as the &#x0201c;best test candidate&#x0201d;. Thus, molecular genetic testing ideally should be performed initially on the &#x0201c;best test candidate&#x0201d; as opposed to a family member who may have an unrelated cancer or who may not have a personal history of cancer. (2) If the &#x0201c;best test candidate&#x0201d; is not available, molecular testing may be performed on another individual, without a cancer history, with the understanding that failure to detect a pathogenic variant does not eliminate the possibility of a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant being present in the family.</p>
          <p>Molecular testing approaches can include a <bold><italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> gene panel</bold> and use of a <bold>multi-gene panel</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> gene panel<italic toggle="yes">.</italic></bold> Sequence analysis of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> is performed concurrently with deletion/duplication analysis.</p>
              <p>Targeted analysis can be considered in individuals of Ashkenazi Jewish ancestry by starting with targeted testing for three <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> pathogenic founder variants: <italic toggle="yes">BRCA1</italic> c.68_69delAG (BIC: 185delAG) <italic toggle="yes">BRCA1</italic> c.5266dupC (BIC: 5382insC), and <italic toggle="yes">BRCA2</italic> c.5946delT (BIC: 6174delT), which together account for up to 99% of pathogenic variants identified in individuals of Ashkenazi Jewish ancestry. If no pathogenic variant is identified by targeted analysis, it may be appropriate to proceed with sequence and deletion/duplication analyses of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> or a multi-gene panel.</p>
              <p>Note: In a family known to have a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant, at-risk adults may be tested for the family-specific germline pathogenic variant. In most cases, relatives at risk need only be tested for the family-specific germline pathogenic variant, except in the following situations:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals of Ashkenazi Jewish heritage should consider testing for all three founder germline pathogenic variants because of the high population frequency of these founder pathogenic variants as well as reports of the coexistence of more than one founder germline pathogenic variant in some families.</p>
                </list-item>
                <list-item>
                  <p>Individuals with a familial <italic toggle="yes">BRCA1 or BRACA2</italic> pathogenic variant on one side of the family and characteristics of HBOC on the other side of the family may consider sequence analysis and deletion/duplication analysis of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic>, which would (1) detect the familial germline pathogenic variant if present and also (2) address whether a germline pathogenic variant is present on the other side of the family.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A <bold>multi-gene panel</bold> that includes <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> and other genes of interest (see <xref ref-type="sec" rid="brca1.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="brca1.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> Associated Hereditary Breast/Ovarian Cancer (HBOC)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_2">Proportion of <italic toggle="yes">BRCA1/BRCA2</italic> Associated HBOC Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BRCA1</italic>
                  </td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">66%</td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;80%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BRCA2</italic>
                  </td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">34%</td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;80%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_brca1.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="brca1.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="brca1" object-id="brca1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="brca1.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="brca1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="brca1.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="brca1.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="brca1.TF.1.5">
                <label>5. </label>
                <p>The majority of pathogenic variants (&#x02265;80%) in <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> are detected through whole-gene sequencing, with an additional 10% detected through deletion/duplication analysis, which may vary across different populations [<xref ref-type="bibr" rid="brca1.REF.palma.2008.7006">Palma et al 2008</xref>, <xref ref-type="bibr" rid="brca1.REF.ewald.2009.437">Ewald et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.kang.2010.579">Kang et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.judkins.2012.5210">Judkins et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="brca1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="brca1.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">BRCA1-</italic> and <italic toggle="yes">BRCA2-</italic>associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for male and female breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a <italic toggle="yes">BRCA2</italic> pathogenic variant. Estimates of malignancy risk vary considerably depending on the context in which they were derived. The following is a summary of the risk for malignancy in an individual with a germline <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant.</p>
          <table-wrap id="brca1.T.risk_of_malignancy_in_individual" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Risk of Malignancy in Individuals with a Germline <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic>-Pathogenic Variant.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1">Cancer Type</th>
                  <th id="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2">General Population Risk</th>
                  <th id="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Risk for Malignancy&#x000a0;<sup>1</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3" id="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">
                    <italic toggle="yes">BRCA1</italic>
                  </th>
                  <th headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3" id="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">BRCA2</italic>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Breast</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">46%-87%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">38%-84%</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Second primary breast</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2% within 5 years</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">21.1% within 10 yrs<break/>83% by age 70</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">10.8% within 10 yrs<break/>62% by age 70</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Ovarian</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1%-2%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">39%-63%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">16.5%-27%</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Male breast</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.1%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1.2%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Up to 8.9%</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Prostate</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">6% through age 69</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">8.6% by age 65</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">15% by age 65<break/>20% lifetime</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Pancreatic</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.50%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1%-3%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">2%-7%</td>
                </tr>
                <tr>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Melanoma (cutaneous &#x00026; ocular)</bold>
                  </td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1.6%</td>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_1_3 hd_h_brca1.T.risk_of_malignancy_in_individual_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Elevated Risk</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="brca1.TF.2.1">
                <label>1. </label>
                <p><xref ref-type="bibr" rid="brca1.REF.ford.1994.692">Ford et al [1994]</xref>, <xref ref-type="bibr" rid="brca1.REF.easton.1995.265">Easton et al [1995]</xref>, <xref ref-type="bibr" rid="brca1.REF.ford.1998.676">Ford et al [1998]</xref>, <xref ref-type="bibr" rid="brca1.REF.robson.1998.1642">Robson et al [1998]</xref>, <xref ref-type="bibr" rid="brca1.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium [1999]</xref>, <xref ref-type="bibr" rid="brca1.REF.verhoog.2000.119s">Verhoog et al [2000]</xref>, <xref ref-type="bibr" rid="brca1.REF.satagopan.2002.3776">Satagopan et al [2002]</xref>, <xref ref-type="bibr" rid="brca1.REF.thompson.2002.1358">Thompson &#x00026; Easton [2002]</xref>, <xref ref-type="bibr" rid="brca1.REF.hearle.2003.458">Hearle et al [2003]</xref>, <xref ref-type="bibr" rid="brca1.REF.kirova.2005.2304">Kirova et al [2005]</xref>, <xref ref-type="bibr" rid="brca1.REF.robson.2005.44">Robson et al [2005]</xref>, <xref ref-type="bibr" rid="brca1.REF.van_asperen.2005.711">van Asperen et al [2005]</xref>, <xref ref-type="bibr" rid="brca1.REF.chen.2006.863">Chen et al [2006]</xref>, <xref ref-type="bibr" rid="brca1.REF.risch.2006.1694">Risch et al [2006]</xref>, <xref ref-type="bibr" rid="brca1.REF.tai.2007.1811">Tai et al [2007]</xref>, <xref ref-type="bibr" rid="brca1.REF.graeser.2009.5887">Graeser et al [2009]</xref>, <xref ref-type="bibr" rid="brca1.REF.evans.2010.710">Evans et al [2010]</xref>, <xref ref-type="bibr" rid="brca1.REF.van_der_kolk.2010.643">van der Kolk et al [2010]</xref>, <xref ref-type="bibr" rid="brca1.REF.kotejarai.2011.1230">Kote-Jarai et al [2011]</xref>, <xref ref-type="bibr" rid="brca1.REF.iqbal.2012.2005">Iqbal et al [2012]</xref>, <xref ref-type="bibr" rid="brca1.REF.leongamornlert.2012.1697">Leongamornlert et al [2012]</xref>, <xref ref-type="bibr" rid="brca1.REF.moran.2012.235">Moran et al [2012]</xref>, <xref ref-type="bibr" rid="brca1.REF.mavaddat.2013.812">Mavaddat et al [2013]</xref>, <xref ref-type="bibr" rid="brca1.REF.van_den_broek.2015.e0120189">van den Broek et al [2015]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Breast cancer.</bold> Breast cancer is the most common malignancy in individuals with a germline <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant with a lifetime risk ranging from 46% to 87%.</p>
          <p>The first estimates of breast cancer risk associated with <italic toggle="yes">BRCA1</italic> pathogenic variants was based on 33 families with evidence of linkage to <italic toggle="yes">BRCA1</italic> with an estimated cumulative risk of 87% by age 70 years [<xref ref-type="bibr" rid="brca1.REF.ford.1994.692">Ford et al 1994</xref>]. For <italic toggle="yes">BRCA2</italic>, early cumulative breast cancer risk estimates reached 84% by age 70 years [<xref ref-type="bibr" rid="brca1.REF.ford.1998.676">Ford et al 1998</xref>]. Subsequent studies have revealed lower risk estimates. In a US study that included 676 Ashkenazi families and 1272 families of other ethnicities, <xref ref-type="bibr" rid="brca1.REF.chen.2006.863">Chen et al [2006]</xref> estimated the cumulative breast cancer risk in women with a germline <italic toggle="yes">BRCA1</italic> pathogenic variant to age 70 years at 46%. <xref ref-type="bibr" rid="brca1.REF.satagopan.2001.467">Satagopan et al [2001]</xref> studied incident breast cancer cases among Ashkenazi Jewish women and found the penetrance of breast cancer at age 80 years among <italic toggle="yes">BRCA1</italic> heterozygotes to be 59% (95% CI = 40%-93%) and among <italic toggle="yes">BRCA2</italic> heterozygotes to be 38% (95% CI = 20%-68%). More recently, in a cohort of 978 individuals with a <italic toggle="yes">BRCA1</italic> pathogenic variant and 909 individuals with a <italic toggle="yes">BRCA2</italic> pathogenic variant from the United Kingdom, <xref ref-type="bibr" rid="brca1.REF.mavaddat.2013.812">Mavaddat et al [2013]</xref> estimated the average cumulative breast cancer risks by age 70 in <italic toggle="yes">BRCA1</italic> heterozygotes to be 60% and 55% for <italic toggle="yes">BRCA2</italic> heterozygotes (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p>A total of 16 studies comprising 10,180 individuals were recently analyzed to determine overall survival among those with <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants [<xref ref-type="bibr" rid="brca1.REF.templeton.2016.e0154789">Templeton et al 2016</xref>]. The pooled analysis showed no association between the presence of germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants and overall survival (HR 1.06, 95% CI 0.84-1.34, p=0.61). The findings were similar when the influence of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> pathogenic variants were evaluated on overall survival independently (<italic toggle="yes">BRCA1</italic>: HR 1.20, 95% CI 0.89-1.61, p=0.24; <italic toggle="yes">BRCA2</italic>: HR 1.01, 95% CI 0.80-1.27, p = 0.95). There, however, appears to be a strong and statistically significant association between estrogen receptor (ER) expression and overall survival in individuals with germline <italic toggle="yes">BRCA1</italic> pathogenic variants but not with age or progesterone receptor (PR) expression.</p>
          <p><italic toggle="yes">BRCA1</italic>-related tumors show an excess of medullary histopathology, are of higher histologic grade, are more likely than sporadic tumors to be estrogen receptor-negative and progesterone receptor-negative, and are less likely to demonstrate HER2/neu overexpression; thus, <italic toggle="yes">BRCA1</italic>-related tumors fall within the category of &#x0201c;triple-negative&#x0201d; breast cancer [<xref ref-type="bibr" rid="brca1.REF.rakha.2008.2568">Rakha et al 2008</xref>, <xref ref-type="bibr" rid="brca1.REF.lee.2011.4373">Lee et al 2011</xref>] and overlap with basal-like breast cancers. Several reports have also suggested a link between germline <italic toggle="yes">BRCA2</italic> pathogenic variants and triple-negative breast cancer. In studies of persons with triple-negative breast cancer, the incidence of germline <italic toggle="yes">BRCA2</italic> pathogenic variants ranges from 3% to 17% [<xref ref-type="bibr" rid="brca1.REF.evans.2011.520">Evans et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.meyer.2012.e38361">Meyer et al 2012</xref>, <xref ref-type="bibr" rid="brca1.REF.couch.2015.304">Couch et al 2015</xref>]. The evidence that a germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant is associated with poor survival outcomes for breast cancer has been inconsistent [<xref ref-type="bibr" rid="brca1.REF.verhoog.2000.119s">Verhoog et al 2000</xref>, <xref ref-type="bibr" rid="brca1.REF.bordeleau.2010.13">Bordeleau et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.van_den_broek.2015.e0120189">van den Broek et al 2015</xref>, <xref ref-type="bibr" rid="brca1.REF.zhong.2015.211">Zhong et al 2015</xref>].</p>
          <p><bold>Contralateral breast cancer (CBC).</bold> Several studies have reported higher rates of CBC [<xref ref-type="bibr" rid="brca1.REF.graeser.2009.5887">Graeser et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.malone.2010.2404">Malone et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.pierce.2010.389">Pierce et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.van_der_kolk.2010.643">van der Kolk et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.metcalfe.2011a.1384">Metcalfe et al 2011a</xref>, <xref ref-type="bibr" rid="brca1.REF.vichapat.2012.3478">Vichapat et al 2012</xref>, <xref ref-type="bibr" rid="brca1.REF.van_den_broek.2015.e0120189">van den Broek et al 2015</xref>] in women treated conservatively. Predictors of CBC include age at first breast cancer, family history of early-onset breast cancer, and the affected <italic toggle="yes">BRCA</italic> gene [<xref ref-type="bibr" rid="brca1.REF.graeser.2009.5887">Graeser et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.malone.2010.2404">Malone et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.metcalfe.2011a.1384">Metcalfe et al 2011a</xref>, <xref ref-type="bibr" rid="brca1.REF.van_den_broek.2015.e0120189">van den Broek et al 2015</xref>]. The risk for CBC was decreased among women who had undergone prophylactic oophorectomy [<xref ref-type="bibr" rid="brca1.REF.metcalfe.2011a.1384">Metcalfe et al 2011a</xref>]. In an unselected cohort of individuals with breast cancer, ten-year cumulative contralateral breast cancer risks of 21.1% for those with <italic toggle="yes">BRCA1</italic> pathogenic variants and 10.8% for those with <italic toggle="yes">BRCA2</italic> pathogenic variants were found.</p>
          <p>Using a cohort of 978 <italic toggle="yes">BRCA1</italic> and 909 <italic toggle="yes">BRCA2</italic> heterozygotes from the United Kingdom, Mavaddat et al estimated the cumulative risk of contralateral breast cancer to be 83% in <italic toggle="yes">BRCA1</italic> heterozygotes and 62% for <italic toggle="yes">BRCA2</italic> heterozygotes by age 70 [<xref ref-type="bibr" rid="brca1.REF.mavaddat.2013.812">Mavaddat et al 2013</xref>].</p>
          <p><bold>Ipsilateral breast cancer.</bold> Two case-control studies reported significantly higher rates of ipsilateral breast cancer in individuals with a germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant compared with sporadic controls [<xref ref-type="bibr" rid="brca1.REF.haffty.2002.1471">Haffty et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.seynaeve.2004.1150">Seynaeve et al 2004</xref>], however, other studies have not found an increased risk for ipsilateral breast cancer in those with germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants when compared with women who had sporadic breast cancer [<xref ref-type="bibr" rid="brca1.REF.robson.2004.r8">Robson et al 2004</xref>, <xref ref-type="bibr" rid="brca1.REF.graeser.2009.5887">Graeser et al 2009</xref>] and also demonstrated a significant ipsilateral breast cancer risk reduction in individuals receiving radiation therapy compared with those who were not receiving radiation therapy [<xref ref-type="bibr" rid="brca1.REF.metcalfe.2011b.287">Metcalfe et al 2011b</xref>].</p>
          <p><bold>Ovarian cancer (including fallopian tube and primary peritoneal cancers).</bold>
<italic toggle="yes">BRCA</italic> germline pathogenic variants confer an excessive risk for ovarian cancer ranging from 16.5% to 63%. The first estimates of ovarian cancer risk associated with <italic toggle="yes">BRCA1</italic> pathogenic variants were as high as 63% by age 70 [<xref ref-type="bibr" rid="brca1.REF.easton.1995.265">Easton et al 1995</xref>] and for <italic toggle="yes">BRCA2</italic> pathogenic variants were as high as 27% by age 70 [<xref ref-type="bibr" rid="brca1.REF.ford.1998.676">Ford et al 1998</xref>]. Subsequent studies have revealed lower risk estimates. In the US population study that included 676 Ashkenazi families and 1272 families of other ethnicities, <xref ref-type="bibr" rid="brca1.REF.chen.2006.863">Chen et al [2006]</xref> estimated ovarian cancer risk to age 70 years in individuals with a germline <italic toggle="yes">BRCA1</italic> pathogenic variant at 39% (95% CI = 0.30%-0.50%). <xref ref-type="bibr" rid="brca1.REF.satagopan.2002.3776">Satagopan et al [2002]</xref> found the estimated penetrance of ovarian cancer at age 70 years among <italic toggle="yes">BRCA1</italic> heterozygotes to be 37% (95% CI = 25%-71%) and among <italic toggle="yes">BRCA2</italic> heterozygotes to be 21% (95% CI = 13%-41%). More recently, in a cohort of 978 <italic toggle="yes">BRCA1</italic> and 909 <italic toggle="yes">BRCA2</italic> heterozygotes from the United Kingdom, <xref ref-type="bibr" rid="brca1.REF.mavaddat.2013.812">Mavaddat et al [2013]</xref> estimated the average cumulative risks by age 70 in <italic toggle="yes">BRCA1</italic> heterozygotes to be 59% for ovarian cancer and 16.5% for <italic toggle="yes">BRCA2</italic> heterozygotes (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p>An excess of serous adenocarcinomas have been observed in women with germline <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variants [<xref ref-type="bibr" rid="brca1.REF.mclaughlin.2013.141">McLaughlin et al 2013</xref>]. Serous adenocarcinomas are generally of higher grade and exhibit prominent intraepithelial lymphocytes, marked nuclear atypia, and abundant mitoses [<xref ref-type="bibr" rid="brca1.REF.fujiwara.2012.1170">Fujiwara et al 2012</xref>]. Given recent advances in the understanding of the molecular pathways of ovarian cancer, it has been concluded that most cases of high-grade serous cancers arise from the fallopian tubes rather than the ovaries [<xref ref-type="bibr" rid="brca1.REF.daly.2015.342">Daly et al 2015</xref>].</p>
          <p>Studies on ovarian cancer survival in women with a germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant have yielded conflicting results. A pooled analysis of 26 observational studies found a more favorable survival rate among individuals with a detectable <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant compared to individuals without a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant, (<italic toggle="yes">BRCA1</italic> HR 0.78, 95% CI 0.68-0.89; <italic toggle="yes">BRCA2</italic> HR 0.61, 95% CI 0.50-0.76). These results persisted when controlling for stage, grade, histology, and age at diagnosis [<xref ref-type="bibr" rid="brca1.REF.bolton.2012.382">Bolton et al 2012</xref>]. A large population-based case-control study found a higher response to platinum-based therapy, longer progression-free survival, and improved overall survival among individuals with a germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant [<xref ref-type="bibr" rid="brca1.REF.alsop.2012.2654">Alsop et al 2012</xref>]. Similarly, individuals with platinum-sensitive epithelial ovarian tumors were more likely to have germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants than individuals with platinum-resistant tumors [<xref ref-type="bibr" rid="brca1.REF.dann.2012.677">Dann et al 2012</xref>]. More recently, in a large series of unselected individuals with ovarian cancer, the short-term survival of individuals with ovarian cancer with germline <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants was better than that of individuals without an identified BRCA1/2 pathogenic variant, however, the survival advantage was short lived and did not lead to a long-term survival benefit [<xref ref-type="bibr" rid="brca1.REF.mclaughlin.2013.141">McLaughlin et al 2013</xref>].</p>
          <p><bold>Male breast cancer.</bold> Based on data from 1939 families with 97 male subjects with breast cancer, the risk of developing breast cancer in males with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant were evaluated. The cumulative risk of breast cancer was higher in both <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> male heterozygotes than in males without a <italic toggle="yes">BRCA1/2</italic> pathogenic variant at all ages. With respect to the relative risks of developing breast cancer, the risk was higher for men in their 30s and 40s and decreased with increasing age. When compared to <italic toggle="yes">BRCA1</italic>, males with <italic toggle="yes">BRCA2</italic> pathogenic variants had higher relative and cumulative risks. The estimated cumulative risk of breast cancer for males with <italic toggle="yes">BRCA1</italic> pathogenic variants at age 70 years was 1.2% (95% CI 0.22%-2.8%) and for males with a <italic toggle="yes">BRCA2</italic> pathogenic variant was 6.8% (95% CI 3.2%-12%) [<xref ref-type="bibr" rid="brca1.REF.tai.2007.1811">Tai et al 2007</xref>].</p>
          <p>In the largest study of families with BRCA2 to date, using both retrospective and prospective analyses of 321 families, three breast cancers occurred in male first-degree relatives, suggesting a risk for male breast cancer to 80 years of 8.9% [<xref ref-type="bibr" rid="brca1.REF.evans.2010.710">Evans et al 2010</xref>] (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p><bold>Prostate cancer.</bold> A series of 913 males with prostate cancer, ranging in age from 36 to 86 years, were screened for germline <italic toggle="yes">BRCA1</italic> pathogenic variants; four pathogenic variants were identified; three of which were identified in individuals diagnosed at or before age 65 years. Based on previously estimated population frequencies of <italic toggle="yes">BRCA1</italic> pathogenic variants, it was estimated that <italic toggle="yes">BRCA1</italic> pathogenic variants confer a relative risk of prostate cancer of approximately 3.7-fold (95% CI 1.02-9.6), which translates to an 8.6% cumulative risk by age 65 years [<xref ref-type="bibr" rid="brca1.REF.leongamornlert.2012.1697">Leongamornlert et al 2012</xref>].</p>
          <p>The lifetime risk for prostate cancer in males with <italic toggle="yes">BRCA2</italic> pathogenic variants has been estimated at 20% [<xref ref-type="bibr" rid="brca1.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium 1999</xref>]. In 2011, Kote-Jarai et al screened 1864 males with prostate cancer diagnosed between age 36 and 88 years for <italic toggle="yes">BRCA2</italic> pathogenic variants. Nineteen protein-truncating variants were identified, all of which occurred in individuals who were diagnosed with prostate cancer at or before age 65 years. Based on previously estimated frequencies of <italic toggle="yes">BRCA2</italic> pathogenic variants, it was estimated that <italic toggle="yes">BRCA2</italic> pathogenic variants confer an increased relative risk of prostate cancer of approximately 8.6-fold (95% CI 5.1-12.6) by age 65 years corresponding to an absolute risk of approximately 15% by age 65 years [<xref ref-type="bibr" rid="brca1.REF.kotejarai.2011.1230">Kote-Jarai et al 2011</xref>]. In addition, <italic toggle="yes">BRCA2</italic>-related prostate cancer has been associated with a higher histologic grade [<xref ref-type="bibr" rid="brca1.REF.gallagher.2010.2115">Gallagher et al 2010</xref>] and results in a poorer overall survival [<xref ref-type="bibr" rid="brca1.REF.thorne.2011.1002">Thorne et al 2011</xref>] (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p><bold>Pancreatic cancer.</bold> An increased risk for pancreatic (adenocarcinoma) cancer has been associated with pathogenic variants in <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic>. In the cross-sectional study of The <xref ref-type="bibr" rid="brca1.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium [1999]</xref>, <xref ref-type="bibr" rid="brca1.REF.thompson.2002.1358">Thompson &#x00026; Easton [2002]</xref> reported a significant increase in the risk for pancreatic cancer in those with germline <italic toggle="yes">BRCA1</italic> pathogenic variants (RR=2.26, 95% CI=1.26-4.06, P=0.004) and in those with <italic toggle="yes">BRCA2</italic> pathogenic variants (RR=3.51, 95% CI=1.87-6.58, P=0.0012). <xref ref-type="bibr" rid="brca1.REF.risch.2006.1694">Risch et al [2006]</xref> estimated the risk of pancreatic cancer among relatives of females with invasive ovarian cancer in 1171 unselected females with ovarian cancer in Ontario. The relative risk for pancreatic cancer was 3.1 (95% CI=0.45-21) in relatives of those with <italic toggle="yes">BRCA1</italic> pathogenic variants and 6.6% (95% CI=1.9-23) in relatives of those with <italic toggle="yes">BRCA2</italic> pathogenic variants, compared to relatives of those without pathogenic variants. More recently, a prospective study of 5149 females with <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variants showed a statistically significant 2.4-fold increase in the incidence of pancreatic cancer and &#x02013; unlike in previous studies &#x02013; the increase in the incidence of pancreatic cancer was similar for <italic toggle="yes">BRCA1</italic> (SIR=2.55) and <italic toggle="yes">BRCA2</italic> (SIR=2.13) [<xref ref-type="bibr" rid="brca1.REF.iqbal.2012.2005">Iqbal et al 2012</xref>] (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p><bold>Melanoma.</bold> Although it is less well studied, the literature suggests that melanoma risk, both cutaneous and ocular, may be elevated in some but not all families with a <italic toggle="yes">BRCA2</italic> pathogenic variant [<xref ref-type="bibr" rid="brca1.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium 1999</xref>, <xref ref-type="bibr" rid="brca1.REF.hearle.2003.458">Hearle et al 2003</xref>, <xref ref-type="bibr" rid="brca1.REF.van_asperen.2005.711">van Asperen et al 2005</xref>]. An analysis of 490 families with <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants showed an increased risk for ocular melanoma in individuals with germline <italic toggle="yes">BRCA2</italic> pathogenic variants (RR=99.4, 95%CI=11.1-359.8) [<xref ref-type="bibr" rid="brca1.REF.moran.2012.235">Moran et al 2012</xref>] (see <xref ref-type="table" rid="brca1.T.risk_of_malignancy_in_individual">Table 2</xref>).</p>
          <p><bold>Other cancers.</bold> In addition to the above-mentioned cancers, individuals with <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> pathogenic variants may be at a higher risk for additional malignancies based on family-based studies as well as case-control studies [The <xref ref-type="bibr" rid="brca1.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium 1999</xref>, <xref ref-type="bibr" rid="brca1.REF.thompson.2001.410">Thompson et al 2001</xref>, <xref ref-type="bibr" rid="brca1.REF.van_asperen.2005.711">van Asperen et al 2005</xref>], although the absolute risks for these other cancers are small. The Breast Cancer Linkage Consortium reported an increased relative risk for cancers of the uterine body and cervix, with relative risks of 2.6 and 3.7, in women younger than age 65 years with a germline <italic toggle="yes">BRCA1</italic> pathogenic variant [<xref ref-type="bibr" rid="brca1.REF.thompson.2002.1358">Thompson &#x00026; Easton 2002</xref>]. The Netherlands Collaborative Group on Hereditary Breast Cancer reported statistically increased relative risks for cancers of the gallbladder and bile duct, with relative risks of 3.5 and 5.0, respectively [<xref ref-type="bibr" rid="brca1.REF.van_asperen.2005.711">van Asperen et al 2005</xref>]. It is important to note, however, that in some of these studies, diagnoses were not consistently confirmed by pathology and therefore, excess risk of cervix and uterus as well as gallbladder and bile duct cancers may represent misclassifications of ovarian and pancreatic cancers, respectively. Furthermore, data suggesting a causative link between endometrial cancer and pathogenic variants of <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> may be related to tamoxifen exposure [<xref ref-type="bibr" rid="brca1.REF.beiner.2007.7">Beiner et al 2007</xref>] rather than the presence of a pathogenic variant, as previous studies have found that uterine papillary serous cancer does not appear to be a manifestation of HBOC [<xref ref-type="bibr" rid="brca1.REF.goshen.2000.477">Goshen et al 2000</xref>]. Finally, initial reports of increased colorectal cancer risk have generally not been replicated [<xref ref-type="bibr" rid="brca1.REF.gruber.2002.1344">Gruber &#x00026; Petersen 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.niell.2004.15">Niell et al 2004</xref>].</p>
          <p>No associated benign tumors or physical abnormalities are presently known to be associated with pathogenic variants in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic>.</p>
        </sec>
        <sec id="brca1.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>Ovarian cancer and primary papillary serous carcinoma of the peritoneum are considerably more common and tend to develop at an earlier age in women with a germline <italic toggle="yes">BRCA1</italic> pathogenic variant as compared to women with a germline <italic toggle="yes">BRCA2</italic> pathogenic variant [<xref ref-type="bibr" rid="brca1.REF.casey.2005.457">Casey et al 2005</xref>, <xref ref-type="bibr" rid="brca1.REF.yates.2011.463">Yates et al 2011</xref>]. However, those with <italic toggle="yes">BRCA2</italic> pathogenic variants tend to be at greater risk for male breast cancer, prostate cancer, pancreatic cancer, and melanoma.</p>
        </sec>
        <sec id="brca1.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Some genotype-phenotype correlations have been identified in families with <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> pathogenic variants. Such correlations are not currently used in individual risk assessment and management, but may be in future with appropriate validation.</p>
          <p>Families with protein-truncating <italic toggle="yes">BRCA1</italic> pathogenic variants from the Breast Cancer Linkage Consortium reported breast cancer risk to be lower with pathogenic variants in the central region of the gene (nucleotides 2,401-4,190) compared with surrounding regions. Furthermore, ovarian cancer risk was associated with a lower risk with pathogenic variants 3&#x02019; to nucleotide 4,191 [<xref ref-type="bibr" rid="brca1.REF.thompson.2001.410">Thompson et al 2001</xref>].</p>
          <p>Studies in the Ashkenazi Jewish population have also found higher rates of ovarian cancer in individuals with the c.68_69delAG (BIC: 185delAG) pathogenic variant, in the 5&#x02019; end of <italic toggle="yes">BRCA1,</italic> as compared to individuals with the c.5266dupC (BIC: 5382insC) pathogenic variant, which is in the 3&#x02019; end of the gene [<xref ref-type="bibr" rid="brca1.REF.lubinski.2004.1">Lubinski et al 2004</xref>]. However, c.5266dupC pathogenic variants appear to confer a higher risk for breast cancer, including bilateral breast cancer, and both breast and ovarian cancer in the same individual when compared to both c.68_69delAG (BIC: 185delAG) in <italic toggle="yes">BRCA1</italic> and c.5946delT (BIC: 6174delT) in <italic toggle="yes">BRCA2</italic> [<xref ref-type="bibr" rid="brca1.REF.satagopan.2002.3776">Satagopan et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.lubinski.2004.1">Lubinski et al 2004</xref>].</p>
          <p>An ovarian cancer cluster region (OCCR) in or near exon 11 in both <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> has been identified [<xref ref-type="bibr" rid="brca1.REF.rebbeck.2015.1347">Rebbeck et al 2015</xref>]. Pathogenic variants within the OCCR have been associated with a higher ratio of ovarian to breast cancer than is seen in families with a pathogenic variant elsewhere in the genes.</p>
          <p>In <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic>, multiple breast cancer cluster regions (BCCR) have been observed and are associated with relatively elevated breast cancer risk and lower ovarian cancer risk [<xref ref-type="bibr" rid="brca1.REF.rebbeck.2015.1347">Rebbeck et al 2015</xref>].</p>
        </sec>
        <sec id="brca1.Penetrance_Cancer_Risk">
          <title>Penetrance (Cancer Risk)</title>
          <p>Female breast and ovarian cancers remain the most common cancers associated with <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants. Females with <italic toggle="yes">BRCA1</italic>/2 pathogenic variants have up to an 87% risk of developing an associated cancer, while males have up to a 20% risk.</p>
        </sec>
        <sec id="brca1.Prevalence">
          <title>Prevalence</title>
          <p><italic toggle="yes">BRCA1</italic>- and <italic toggle="yes">BRCA2-</italic>associated hereditary breast and ovarian cancer (HBOC) is the most common form of hereditary breast and ovarian cancer and occurs in all ethnic and racial populations. The prevalence of <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants in the general population (excluding Ashkenazim) is estimated at 1:400 to 1:500 [<xref ref-type="bibr" rid="brca1.REF.anglian_breast_cancer_study_group.2000.1301">Anglian Breast Cancer Study Group 2000</xref>, <xref ref-type="bibr" rid="brca1.REF.whittemore.2004b.2078">Whittemore et al 2004b</xref>].</p>
          <p><bold>Ashkenazi Jewish.</bold> The combined frequency of the following three pathogenic variants in the Ashkenazi Jewish population is 1:40 [<xref ref-type="bibr" rid="brca1.REF.king.2003.643">King et al 2003</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">BRCA1</italic> c.68_69delAG</bold> (BIC: 185delAG) occurs with a frequency of 1%;</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">BRCA1</italic></bold>
<bold>c.5266dupC</bold> (BIC: 5382insC) has an estimated prevalence of 0.1%-0.15%;</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">BRCA2</italic> c.5946delT</bold> (BIC: 6174delT) occurs with a frequency of about 1.52%.</p>
            </list-item>
          </list>
          <p>[<xref ref-type="bibr" rid="brca1.REF.ferla.2007.vi93">Ferla et al 2007</xref>]</p>
        </sec>
      </sec>
      <sec id="brca1.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Germline pathogenic variants in <italic toggle="yes">BRCA2</italic> have been associated with the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Familial pancreatic cancer [<xref ref-type="bibr" rid="brca1.REF.ferrone.2009.433">Ferrone et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.iqbal.2012.2005">Iqbal et al 2012</xref>, <xref ref-type="bibr" rid="brca1.REF.mocci.2013.803">Mocci et al 2013</xref>]</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia</related-object> complementation group FANCD1 [<xref ref-type="bibr" rid="brca1.REF.howlett.2002.606">Howlett et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.stecklein.2012.178">Stecklein &#x00026; Jensen 2012</xref>]</p>
          </list-item>
        </list>
      </sec>
      <sec id="brca1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Syndromic breast cancer.</bold> Individuals with the following cancer susceptibility syndromes and/or genes have an elevated breast cancer risk. In many instances, <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> HBOC can be distinguished from these other disorders based on the constellation of tumors present in the family; however, in some cases, molecular genetic testing may be necessary to differentiate.</p>
        <table-wrap id="brca1.T.disorders_to_consider_in_the_dif" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of <italic toggle="yes">BRCA1-</italic> and <italic toggle="yes">BRCA2-</italic>Associated Hereditary Breast and Ovarian Cancer</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cancer Susceptibility Syndrome / Gene</th>
                <th id="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene(s)</th>
                <th id="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">MOI</th>
                <th id="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Lifetime Breast Cancer Risk &#x00026; Other Associated Cancers</th>
                <th id="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other Distinguishing Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="li-fraumeni" document-type="chapter">Li-Fraumeni syndrome</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TP53</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer &#x02264;79%&#x000a0;<sup>1</sup><break/>(often pre-menopausal)<break/>Soft tissue sarcoma<break/>Osteosarcoma<break/>Brain tumors<break/>Adrenocortical carcinoma<break/>Leukemias</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Cancers often occur in childhood or young adulthood.<break/>Survivors are at increased risk for multiple primary cancers.</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cowden syndrome<break/>(see <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> Hamartoma Tumor Syndrome</related-object>)</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PTEN</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer 25%-50%, may be &#x02264;85%&#x000a0;<sup>2</sup><break/>Thyroid cancer<break/>Renal cell carcinoma<break/>Endometrial carcinoma<break/>Colorectal cancer</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Multiple hamartomas, macrocephaly, trichilemmomas, papillomatous papules<break/>Affected individuals usually present by late 20s</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="hgc" document-type="chapter">Hereditary diffuse gastric cancer</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">CDH1</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer 39%-52%&#x000a0;<sup>3</sup><break/>(lobular breast cancer)<break/>Diffuse gastric cancer</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Majority of cancers occur before age 40 years</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">CHEK2</italic><break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604373">604373</ext-link>)</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">CHEK2</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer 25%-39%&#x000a0;<sup>4</sup><break/>Prostate cancer&#x000a0;<sup>5</sup><break/>Stomach cancer&#x000a0;<sup>5</sup><break/>Sarcoma&#x000a0;<sup>5</sup><break/>Kidney cancer&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">ATM</italic> heterozygotes<break/>(see <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">Ataxia-Telangiectasia</related-object>)</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATM</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer 17%-52%&#x000a0;<sup>6</sup><break/>Other cancers</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">PALB2</italic><break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610355">610355</ext-link>)</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PALB2</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer &#x02264;58%&#x000a0;<sup>7</sup><break/>Male breast cancer&#x000a0;<sup>8</sup><break/>Pancreatic cancer <sup>9</sup></td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pjs" document-type="chapter">Peutz-Jeghers syndrome</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">STK11</italic>&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer 32%-54%<break/>Gastrointestinal malignancies<break/>Ovarian (mostly SCTAT)<break/>Cervical cancer (adenoma malignum)<break/>Uterine cancer<break/>Pancreatic cancer<break/>Sertoli cell testicular cancer<break/>Lung cancer</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Gastrointestinal polyposis, mucocutaneous pigmentation, hyperpigmented macules on the fingers</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="bloom" document-type="chapter">Bloom&#x02019;s syndrome</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">BLM</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer risk increased&#x000a0;<sup>10</sup><break/>Epithelial carcinoma<break/>Lymphoma<break/>Leukemia<break/>Other cancers</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe pre- &#x00026; postnatal growth deficiency, sparse subcutaneous fat tissue, short stature, sun-sensitive, erythematous skin lesion of the face</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="werner" document-type="chapter">Werner syndrome</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">WRN</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer risk increased&#x000a0;<sup>11</sup><break/>Sarcomas<break/>Melanoma<break/>Thyroid cancer<break/>Hematologic malignancies</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Characterized by the appearance, usually in the 20s, of features associated w/normal aging</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">RAD51C</italic><break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/602774">602774</ext-link>)</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">RAD51C</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Breast cancer risk unknown</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="hnpcc" document-type="chapter">Lynch syndrome</related-object>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MLH1</italic>
                  <break/>
                  <italic toggle="yes">MSH2</italic>
                  <break/>
                  <italic toggle="yes">MSH6</italic>
                  <break/>
                  <italic toggle="yes">PMS2</italic>
                  <break/>
                  <italic toggle="yes">EPCAM</italic>
                </td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Ovarian cancer&#x000a0;<sup>12</sup><break/>Nonpolyposis colorectal cancer<break/>Endometrial cancer<break/>Other cancers</td>
                <td headers="hd_h_brca1.T.disorders_to_consider_in_the_dif_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">It is currently unknown whether Lynch syndrome is associated w/increased risk for breast cancer.&#x000a0;<sup>13</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>RR = relative risk</p>
            </fn>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>SCTAT = sex cord tumor with annular tubules</p>
            </fn>
            <fn>
              <p>XL = X-linked</p>
            </fn>
            <fn id="brca1.TF.3.1">
              <label>1. </label>
              <p>
                <xref ref-type="bibr" rid="brca1.REF.ruijs.2010.421">Ruijs et al [2010]</xref>
              </p>
            </fn>
            <fn id="brca1.TF.3.2">
              <label>2. </label>
              <p>Lifetime breast cancer risk is estimated at between 25% and 50% among women with Cowden syndrome [<xref ref-type="bibr" rid="brca1.REF.hobert.2009.687">Hobert &#x00026; Eng 2009</xref>]. Other studies have reported risks as high as 85% [<xref ref-type="bibr" rid="brca1.REF.tan.2012.400">Tan et al 2012</xref>, <xref ref-type="bibr" rid="brca1.REF.bubien.2013.255">Bubien et al 2013</xref>, <xref ref-type="bibr" rid="brca1.REF.ngeow.2014.1818">Ngeow et al 2014</xref>, <xref ref-type="bibr" rid="brca1.REF.nieuwenhuis.2014.57">Nieuwenhuis et al 2014</xref>]; however, there are concerns regarding selection bias in these studies.</p>
            </fn>
            <fn id="brca1.TF.3.3">
              <label>3. </label>
              <p><xref ref-type="bibr" rid="brca1.REF.brookswilson.2004.508">Brooks-Wilson et al [2004]</xref>, <xref ref-type="bibr" rid="brca1.REF.kaurah.2007.2360">Kaurah et al [2007]</xref></p>
            </fn>
            <fn id="brca1.TF.3.4">
              <label>4. </label>
              <p><italic toggle="yes">CHEK2</italic> variant c.1100delC (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_007194.3">NM_007194.3</ext-link>) associated with estimated two- to threefold increase in breast cancer risk in women and a tenfold increase of risk in men [<italic toggle="yes">CHEK2</italic> Breast Cancer Case-Control Consortium 2004, <xref ref-type="bibr" rid="brca1.REF.bernstein.2006.348">Bernstein et al 2006</xref>, <xref ref-type="bibr" rid="brca1.REF.weischer.2007.57">Weischer et al 2007</xref>]</p>
            </fn>
            <fn id="brca1.TF.3.5">
              <label>5. </label>
              <p>Associated with <italic toggle="yes">CHEK2</italic> founder alleles: c.1100delC, c.319+1G&#x0003e;A(IVS2+1G&#x0003e;A), p.Ile157Thr (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_007194.3">NM_007194.3</ext-link>) [<xref ref-type="bibr" rid="brca1.REF.n_slundkoch.2016.1208">N&#x000e4;slund-Koch et al 2016</xref>]</p>
            </fn>
            <fn id="brca1.TF.3.6">
              <label>6. </label>
              <p>The cancer risk to individuals heterozygous for <italic toggle="yes">ATM</italic> disease-causing variants is approximately four times that of the general population, primarily because of an increased risk for breast cancer [<xref ref-type="bibr" rid="brca1.REF.renwick.2006.873">Renwick et al 2006</xref>, <xref ref-type="bibr" rid="brca1.REF.tavtigian.2009.427">Tavtigian et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.goldgar.2011.r73">Goldgar et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.roberts.2012.41">Roberts et al 2012</xref>]. Some specific pathogenic <italic toggle="yes">ATM</italic> variants may cause an even higher female breast cancer risk (&#x02264;52%-69%).</p>
            </fn>
            <fn id="brca1.TF.3.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="brca1.REF.antoniou.2014.497">Antoniou et al [2014]</xref>
              </p>
            </fn>
            <fn id="brca1.TF.3.8">
              <label>8. </label>
              <p>Male breast cancer has also been observed in families with molecularly confirmed <italic toggle="yes">PALB2</italic>-associated breast cancer [<xref ref-type="bibr" rid="brca1.REF.casadei.2011.2222">Casadei et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.ding.2011.771">Ding et al 2011</xref>].</p>
            </fn>
            <fn id="brca1.TF.3.9">
              <label>9. </label>
              <p>Germline pathogenic variants in <italic toggle="yes">PALB2</italic> have been identified in families with multiple cases of pancreatic cancer, but the exact risk for pancreatic cancer conferred by germline variants in <italic toggle="yes">PALB2</italic> has not yet been established [<xref ref-type="bibr" rid="brca1.REF.jones.2009.217">Jones et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.slater.2010.490">Slater et al 2010</xref>].</p>
            </fn>
            <fn id="brca1.TF.3.10">
              <label>10. </label>
              <p>Sixteen individuals with breast cancer, of 207 individuals with Bloom&#x02019;s syndrome reported in Bloom&#x02019;s Syndrome Registry</p>
            </fn>
            <fn id="brca1.TF.3.11">
              <label>11. </label>
              <p>Seven of 248 neoplasms reported in individuals with Werner syndrome [<xref ref-type="bibr" rid="brca1.REF.lauper.2013.e59709">Lauper et al 2013</xref>]</p>
            </fn>
            <fn id="brca1.TF.3.12">
              <label>12. </label>
              <p>Lifetime risks of ovarian cancer in Lynch syndrome range from 4% to 12%. Unlike ovarian cancer associated with germline pathogenic variants in <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic>, those associated with Lynch syndrome are more likely to be endometrioid or clear cell [<xref ref-type="bibr" rid="brca1.REF.ketabi.2011.462">Ketabi et al 2011</xref>].</p>
            </fn>
            <fn id="brca1.TF.3.13">
              <label>13. </label>
              <p>Breast cancer has been reported in families with Lynch syndrome, but consistent associations have not been demonstrated [<xref ref-type="bibr" rid="brca1.REF.gruber.2002.1344">Gruber &#x00026; Petersen 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.m_ller.2002.1014">M&#x000fc;ller et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.walsh.2010.2214">Walsh et al 2010</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="brca1.Management">
        <title>Management</title>
        <sec id="brca1.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>Individuals who have a germline pathogenic variant in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> are counseled at the time of disclosure of molecular genetic test results about their options for <xref ref-type="sec" rid="brca1.Surveillance">Surveillance</xref> and <xref ref-type="sec" rid="brca1.Prevention_of_Primary_Manifestatio">Prevention of Primary Manifestations</xref>.</p>
        </sec>
        <sec id="brca1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>National Comprehensive Cancer Network (NCCN) guidelines suggest that women with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant could consider bilateral mastectomy as a primary surgical treatment of breast cancer because of their elevated rate of ipsilateral and contralateral breast cancer. See NCCN <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp">guidelines</ext-link> for the treatment of breast cancer and the treatment of other <italic toggle="yes">BRCA1</italic>- and <italic toggle="yes">BRCA2</italic>-associated malignancies (registration required).</p>
        </sec>
        <sec id="brca1.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>
            <bold>Breast cancer</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Consider prophylactic bilateral mastectomy</p>
            </list-item>
            <list-item>
              <p>Given the conflicting data on the degree of risk reduction of breast cancer associated with prophylactic oophorectomy, consider discussing the risks and benefits of this approach with a genetics specialist.</p>
            </list-item>
            <list-item>
              <p>Chemoprevention. In a retrospective study tamoxifen reduced the risk for breast cancer by 62% among healthy women with a <italic toggle="yes">BRCA2</italic> germline variant [<xref ref-type="bibr" rid="brca1.REF.king.2001.2251">King et al 2001</xref>]. The sample size, however, was extremely small. In a nested case-control study, tamoxifen use was associated with a 41%-50% reduction in the risk of developing contralateral breast cancer [<xref ref-type="bibr" rid="brca1.REF.narod.2000.1876">Narod et al 2000</xref>, <xref ref-type="bibr" rid="brca1.REF.metcalfe.2005.222">Metcalfe et al 2005</xref>]. There have been no prospective randomized trials of tamoxifen as a chemoprevention agent in women with BRCA1/2 pathogenic variants.</p>
            </list-item>
            <list-item>
              <p>Breast feeding for a cumulative total of more than one year reduced the risk for breast cancer [<xref ref-type="bibr" rid="brca1.REF.jernstr_m.2004.1094">Jernstr&#x000f6;m et al 2004</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Ovarian cancer/fallopian tube cancer</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Consider prophylactic oophorectomy, recognizing that completion of childbearing may factor into this decision. Several studies have documented a significant (80%-96%) risk reduction in ovarian cancer following risk-reducing oophorectomy [<xref ref-type="bibr" rid="brca1.REF.kauff.2002.1609">Kauff et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.rebbeck.2002.1616">Rebbeck et al 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.rutter.2003.1072">Rutter et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Salpingectomy. Recent advances in understanding the molecular events preceding ovarian cancer have established the fallopian tube as the origin of the majority of high-grade serous ovarian cancers, leading to the consideration of salpingectomy with ovarian retention until the age of natural menopause as the first step in primary prevention. This approach is likely to reduce the health hazards of premature menopause, but its adoption will require prospective data to establish its safety and efficacy [<xref ref-type="bibr" rid="brca1.REF.daly.2015.342">Daly et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Tubal ligation. A meta-analysis of 13 studies showed a reduction in risk for ovarian cancer of 34% in the general population after tubal ligation [<xref ref-type="bibr" rid="brca1.REF.cibula.2011.55">Cibula et al 2011</xref>]. A meta-analysis of modifiers of risk of cancer in individuals with pathogenic variants in <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> found a reduction in the risk of ovarian cancer in females with a <italic toggle="yes">BRCA1</italic> pathogenic variant, although study design issues limit the impact of these findings [<xref ref-type="bibr" rid="brca1.REF.friebel.2014.dju091">Friebel et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Oral contraceptive use has been associated with a reduction in ovarian cancer risk of 14% among women who had ever used oral contraceptives and 38% among long-term users [<xref ref-type="bibr" rid="brca1.REF.whittemore.2004a.1911">Whittemore et al 2004a</xref>].</p>
              <p>Note: There is no evidence that use of current (after 1975) oral contraceptive formulations increases the risk for early-onset breast cancer for women with a germline <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant.</p>
            </list-item>
          </list>
        </sec>
        <sec id="brca1.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Significant adverse consequences of tamoxifen treatment included higher rates of endometrial cancer and thromboembolic episodes (including pulmonary embolism) in those individuals who took the medication than in those who did not. Women with a history of thromboembolic disease or with a coagulation disorder should avoid taking tamoxifen. Women on tamoxifen should be counseled to report any abnormal vaginal bleeding immediately to their gynecologist.</p>
        </sec>
        <sec id="brca1.Surveillance">
          <title>Surveillance</title>
          <p>
            <bold>Women</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Monthly breast self-examination</p>
            </list-item>
            <list-item>
              <p>Clinical breast examination every 6-12 months beginning at age 25</p>
            </list-item>
            <list-item>
              <p>Annual breast MRI beginning at age 25, or individualized based on family history if a breast cancer diagnosis before age 30 is present</p>
            </list-item>
            <list-item>
              <p>Annual mammogram beginning at age 30</p>
            </list-item>
            <list-item>
              <p>Annual transvaginal ultrasound and serum CA-125 concentration beginning at age 35 years (or individualized based on the earliest age of onset in the family) may be considered for those women who have not elected to undergo prophylactic oophorectomy.</p>
              <p>Note: Annual pelvic ultrasound and/or CA-125 concentration has not been effective in detecting early-stage ovarian cancer, either in high-risk or average-risk women.</p>
            </list-item>
          </list>
          <p>
            <bold>Men</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Breast self-examination training and regular monthly breast self-examination beginning at age 35</p>
            </list-item>
            <list-item>
              <p>Annual clinical breast examination beginning at age 35</p>
            </list-item>
            <list-item>
              <p>Annual prostate cancer screening beginning at age 45</p>
            </list-item>
          </list>
          <p>
            <bold>Women and men</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Screening for melanoma should be individualized based on the family history.</p>
            </list-item>
            <list-item>
              <p>Screening of asymptomatic individuals for pancreatic cancer is not generally recommended, but is possible in research settings.</p>
            </list-item>
          </list>
        </sec>
        <sec id="brca1.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>No data specific to individuals with <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variants are available.</p>
        </sec>
        <sec id="brca1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Once a cancer-predisposing <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline variant has been identified in a family, testing of at-risk relatives can identify those family members who also have the familial variant and thus need increased surveillance and early intervention when a cancer is identified.</p>
          <p>See <xref ref-type="sec" rid="brca1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="brca1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Several studies currently underway are looking at novel approaches to the treatment of <italic toggle="yes">BRCA</italic>-associated breast and ovarian cancer. The majority of the studies involve PARP inhibitors, and have led to FDA approval for one of these agents in treatment of recurrent ovarian cancer. Newer studies are exploring the use of PARP inhibitors in other <italic toggle="yes">BRCA</italic>-associated cancers (e.g., pancreatic cancer). Given the experimental data showing increased sensitivity of BRCA cell lines to platinum-based agents, there is interest in platinum-based regimens for breast cancer in the neoadjuvant, adjuvant, and metastatic setting.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="brca1.Other">
          <title>Other</title>
          <p><bold>Hormone replacement therapy (HRT).</bold> General population studies suggest that long-term estrogen replacement therapy in postmenopausal women may increase breast cancer risk, but that short-term use to treat menopausal symptoms does not. However, even relatively short-term combined estrogen plus progestin use was shown to increase the incidence of breast cancers in a randomized, placebo control trial of HRT [<xref ref-type="bibr" rid="brca1.REF.chlebowski.2003.3243">Chlebowski et al 2003</xref>].</p>
          <p>Three observational studies on the impact of HRT on breast cancer risk in <italic toggle="yes">BRCA 1</italic>/<italic toggle="yes">2</italic> heterozygotes have been published. <xref ref-type="bibr" rid="brca1.REF.rebbeck.2005.7804">Rebbeck et al [2005]</xref> evaluated breast cancer risk associated with HRT after bilateral prophylactic oophorectomy in a cohort of 462 women with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant and found that HRT of any type after bilateral prophylactic oophorectomy did not significantly alter the reduction in breast cancer risk associated with the surgery. The postoperative follow up was 3.6 years. It was concluded that short-term HRT does not substantially increase the risk for breast cancer in women with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant. A subsequent study of expanded data from this cohort included 1299 women with a mean follow-up of 5.4 years. There was no increase in breast cancer risk, and a significant decrease in breast cancer risk was found among <italic toggle="yes">BRCA1</italic> heterozygotes [<xref ref-type="bibr" rid="brca1.REF.domchek.2011">Domchek et al 2011</xref>]. In another matched case-control study of 472 postmenopausal women with a <italic toggle="yes">BRCA1</italic> pathogenic variant, the use of HRT was associated with a reduction in breast cancer risk [<xref ref-type="bibr" rid="brca1.REF.eisen.2008.1361">Eisen et al 2008</xref>]. Finally, a case-control study of 432 matched pairs with a mean follow up of 4.3 years also found a decrease in the risk for breast cancer in <italic toggle="yes">BRCA1</italic> heterozygotes [<xref ref-type="bibr" rid="brca1.REF.kotsopoulos.2016.365">Kotsopoulos et al 2016</xref>]. Taken together, these studies support the short-term use of HRT among <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> heterozygotes who have undergone surgical menopause.</p>
        </sec>
      </sec>
      <sec id="brca1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="brca1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> hereditary breast and ovarian cancer syndrome (HBOC) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="brca1.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband with a <italic toggle="yes">BRCA1/2</italic> pathogenic variant</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The vast majority of individuals with a pathogenic germline variant in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> have inherited it from a parent.</p>
            </list-item>
            <list-item>
              <p>The parent with the variant may or may not have had a cancer diagnosis depending on the following variables:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Penetrance of the variant</p>
                </list-item>
                <list-item>
                  <p>Gender of the parent</p>
                </list-item>
                <list-item>
                  <p>Age of the parent</p>
                </list-item>
                <list-item>
                  <p>Cancer risk reduction in the parent as a result of screening or prophylactic surgeries</p>
                </list-item>
                <list-item>
                  <p>Early death of the parent</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>It is appropriate to offer molecular genetic testing to both parents of an individual with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant to determine which side of the family is at risk. Generally, the pattern of cancers seen in the family usually guides which parent is tested first.</p>
            </list-item>
            <list-item>
              <p>Rarely, neither parent will be identified as having the <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant. In the years since the discovery of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">de novo</italic> variants have been reported, but the rate appears to be extremely low in these two genes (&#x02264;5%) based on the few studies performed to date [<xref ref-type="bibr" rid="brca1.REF.hansen.2008.58">Hansen et al 2008</xref>, <xref ref-type="bibr" rid="brca1.REF.marshall.2009.427">Marshall et al 2009</xref>, <xref ref-type="bibr" rid="brca1.REF.diez.2010.221">Diez et al 2010</xref>, <xref ref-type="bibr" rid="brca1.REF.garciacasado.2011.134">Garcia-Casado et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.kwong.2011.233">Kwong et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.zhang.2011.97">Zhang et al 2011</xref>, <xref ref-type="bibr" rid="brca1.REF.de_leeneer.2012.87">De Leeneer et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
<bold>with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant</bold></p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to full sibs of the proband depends on the genetic status of the proband's parents: the risk that a sib of an index case will inherit the <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant is 50% if one parent has the <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline variant.</p>
            </list-item>
            <list-item>
              <p>The risk of developing cancer, however, depends on numerous variables including the penetrance of the pathogenic variant and the gender and age of the individual.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant.</bold> The offspring of an individual identified as having a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant have a 50% chance of inheriting the variant. The risk of developing cancer, however, depends on numerous variables including the penetrance of the pathogenic variant and the gender and age of the individual.</p>
          <p><bold>Other family members of a proband with a <italic toggle="yes">BRCA1</italic>/<italic toggle="yes">2</italic> pathogenic variant.</bold> The risk to other family members depends on the status of the proband's parents. If a parent has a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline variant, his or her family members are at risk. Their exact risk depends on their position in the pedigree.</p>
        </sec>
        <sec id="brca1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="brca1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic> (although rare, <italic toggle="yes">de novo</italic> variants in both <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> have been reported). However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for the determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>Genetic cancer risk assessment and counseling.</bold> For a comprehensive description of the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without molecular genetic testing, see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.gov/about-cancer/causes-prevention/genetics/risk-assessment-pdq">Cancer Genetics Risk Assessment and Counseling &#x02013; for health professionals</ext-link> (part of PDQ<sup>&#x000ae;</sup>, National Cancer Institute).</p>
          <p><bold>At-risk asymptomatic adult relatives.</bold> In general, relatives of an individual who has a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant should be counseled regarding their risk of having inherited the same variant, their options for molecular genetic testing, their cancer risk, and recommendations for cancer screening (see <xref ref-type="sec" rid="brca1.Surveillance">Surveillance</xref>) and prophylactic surgery (see <xref ref-type="sec" rid="brca1.Prevention_of_Primary_Manifestatio">Prevention of Primary Manifestations</xref>).</p>
          <p>At-risk adult relatives who have not inherited the cancer-predisposing germline variant identified in the proband are presumed to be at or above the general population risk of developing cancer, depending on personal risk factors. For example, a female at-risk relative who does not have the family-specific <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant may still be at an elevated risk for breast cancer based on a breast biopsy history that revealed atypical ductal hyperplasia.</p>
          <p>For family members determined to be at general population risk of developing cancer, appropriate cancer screening such as that recommended by the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.org/">American Cancer Society</ext-link> or the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/">National Comprehensive Cancer Network</ext-link> (NCCN) for individuals of average risk is recommended. Note: This presumption cannot apply to individuals who did not have an identifiable <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant if the affected individual in the family either has not undergone molecular genetic testing of <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> or did not have an identified <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years.</bold> In general, genetic testing for HBOC is not recommended for at-risk individuals younger than age 18 years. Guidelines established jointly by the American College of Medical Genetics and the American Society of Human Genetics state that predictive genetic testing should only be performed in individuals younger than age 18 years when it will affect their medical management. Management for HBOC-related cancer is typically recommended to begin at approximately age 25, which is why it is recommended that the decision to test be postponed until an individual reaches adulthood and can make an independent decision. It is important to note, however, that since there are rare reported cases of individuals with HBOC diagnosed with cancer at very young ages, it is recommended that screening be individualized based on the earliest diagnosis in the family.</p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nsgc.org/p/bl/et/blogaid=860">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="brca1.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> germline pathogenic variant has been identified in the family, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for HBOC are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="brca1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="brca1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">BRCA1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">BRCA1</italic> spans more than 80 kb of genomic DNA and encodes a 7.8-kb transcript composed of 24 coding exons [<xref ref-type="bibr" rid="brca1.REF.miki.1994.66">Miki et al 1994</xref>, <xref ref-type="bibr" rid="brca1.REF.deng.2006.1416">Deng 2006</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="brca1" object-id="brca1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 1800 pathogenic variants have been identified in <italic toggle="yes">BRCA1</italic>. While a small number of these variants have been identified repeatedly in unrelated families, the vast majority have not been reported in more than a few families. Overall, among individuals undergoing molecular genetic testing of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic>, approximately 2.9% will have a variant of uncertain clinical significance [<xref ref-type="bibr" rid="brca1.REF.eggington.2012">Eggington et al 2012</xref>] &#x02013; a proportion that has declined significantly over the past ten years. (For more information, see <related-object source-id="gene" document-id="brca1" object-id="brca1.molgen.TA">Table A</related-object>.)</p>
        <p><bold>Reduced-penetrance variant.</bold> p.Arg1699Gln is established to be a reduced penetrance variant in <italic toggle="yes">BRCA1</italic> [<xref ref-type="bibr" rid="brca1.REF.spurdle.2012.525">Spurdle et al 2012</xref>]. Data from functional assays were ambiguous for deficiency across multiple assays. Thus, this allele was determined to be associated with intermediate risk for breast and ovarian cancer, highlighting challenges for risk modeling and clinical management of individuals of this and other potential moderate-risk variants.</p>
        <table-wrap id="brca1.T.selected_brca1_pathogenic_varian" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Selected <italic toggle="yes">BRCA1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.68_69delAG<break/>(185delAG or 187delAG)</td>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu23ValfsTer17</td>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/237757283">NM_007294.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/6552299">NP_009225.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5096G&#x0003e;A</td>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1699Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5266dupC<break/>(5385insC or 5382insC)</td>
                <td headers="hd_h_brca1.T.selected_brca1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln1756ProfsTer74</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="brca1.TF.4.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">BRCA1</italic> codes for a 220-kd protein of 1863 amino acids. The breast cancer type 1 susceptibility protein (BRCA1) is a phosphoprotein normally located in the nucleus [<xref ref-type="bibr" rid="brca1.REF.chen.1996.3168">Chen et al 1996</xref>]. Its functional domains include:</p>
        <list list-type="bullet">
          <list-item>
            <p>A RING finger domain near the N-terminus; may facilitate both protein-protein (BRCA1 / BARD1) and protein-DNA interactions [<xref ref-type="bibr" rid="brca1.REF.boddy.1994.198">Boddy et al 1994</xref>]</p>
          </list-item>
          <list-item>
            <p>Two nuclear localization signals located in exon 11</p>
          </list-item>
          <list-item>
            <p>An "SQ" cluster between p.1280 and p.1524</p>
          </list-item>
          <list-item>
            <p>A BRCT domain at the C-terminus</p>
          </list-item>
        </list>
        <p>BRCA1 interacts with several proteins involved in cellular pathways, including cell-cycle progression, gene transcription regulation, DNA damage response, and ubiquitination [<xref ref-type="bibr" rid="brca1.REF.deng.2006.1416">Deng 2006</xref>, <xref ref-type="bibr" rid="brca1.REF.rosen.2006.175">Rosen et al 2006</xref>].</p>
        <p>The BRCA1/BARD1 protein complex enhances ubiquitin ligase activity, which is associated with the regulation of centrosome function and involved in DNA repair and cell cycle regulation [<xref ref-type="bibr" rid="brca1.REF.sankaran.2006.4100">Sankaran et al 2006</xref>, <xref ref-type="bibr" rid="brca1.REF.bork.1997.68">Bork et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.callebaut.1997.25">Callebaut &#x00026; Mornon 1997</xref>].</p>
        <p>BRCA1 is expressed in most tissues and cell types analyzed, suggesting that it is not the gene expression pattern that leads to the tissue-restricted phenotype of breast and ovarian cancer. The transcription of <italic toggle="yes">BRCA1</italic> is induced late in the G<sub>1</sub> phase of the cell cycle and remains elevated during the S phase, indicating some role in DNA synthesis [<xref ref-type="bibr" rid="brca1.REF.gudas.1996.717">Gudas et al 1996</xref>, <xref ref-type="bibr" rid="brca1.REF.rajan.1996.13078">Rajan et al 1996</xref>]. A variety of evidence now points to the breast cancer type 1 susceptibility protein as being directly involved in the DNA repair process.</p>
        <p>BRCA1 colocalizes with BRCA2 and RAD51 at sites of DNA damage and activates RAD51-mediated homologous recombination repair of DNA double-strand breaks [<xref ref-type="bibr" rid="brca1.REF.cousineau.2005.11384">Cousineau et al 2005</xref>]. One of the targets of <italic toggle="yes">BRCA1</italic> transcriptional activation appears to be the p21 cyclin-dependent kinase inhibitor, itself a potent suppressor of growth at the G<sub>1</sub>/S checkpoint [<xref ref-type="bibr" rid="brca1.REF.somasundaram.1997.187">Somasundaram et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.ouchi.1998.2302">Ouchi et al 1998</xref>].</p>
        <p>Complete loss of <italic toggle="yes">Brca1</italic> in the mouse is embryonic lethal, characterized by a lack of cell proliferation [<xref ref-type="bibr" rid="brca1.REF.hakem.1996.1009">Hakem et al 1996</xref>, <xref ref-type="bibr" rid="brca1.REF.ludwig.1997.1226">Ludwig et al 1997</xref>]. Cells derived from mouse embryos lacking <italic toggle="yes">Brca1</italic> are defective in their repair of DNA damage [<xref ref-type="bibr" rid="brca1.REF.gowen.1998.1009">Gowen et al 1998</xref>]. Interestingly, <italic toggle="yes">Brca1</italic> knockout mice can be partially rescued by crossing with a <italic toggle="yes">Tp53</italic> knockout strain, suggesting that these genes interact with the <related-object link-type="booklink" source-id="gene" document-id="li-fraumeni" document-type="chapter"><italic toggle="yes">TP53</italic></related-object>-mediated DNA damage checkpoint [<xref ref-type="bibr" rid="brca1.REF.brugarolas.1997.721">Brugarolas &#x00026; Jacks 1997</xref>]. Therefore, the available evidence indicates that <italic toggle="yes">BRCA1</italic> serves as a &#x0201c;caretaker,&#x0201d; like <italic toggle="yes">TP53</italic>, helping to maintain genomic integrity [<xref ref-type="bibr" rid="brca1.REF.zhang.1998.433">Zhang et al 1998</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Most <italic toggle="yes">BRCA1</italic> pathogenic variants lead to frameshifts resulting in a missing or non-functional protein. In cancers from individuals with a <italic toggle="yes">BRCA1</italic> germline pathogenic variant, the normal allele is deleted or inactivated, resulting in somatic inactivation of <italic toggle="yes">BRCA1</italic>. This strongly suggests that <italic toggle="yes">BRCA1</italic> is a tumor-suppressor gene whose loss of function can result in genomic instability, resulting in a high susceptibility to malignant transformation [<xref ref-type="bibr" rid="brca1.REF.smith.1992.128">Smith et al 1992</xref>, <xref ref-type="bibr" rid="brca1.REF.deng.2006.1416">Deng 2006</xref>]. Additional evidence in support of a tumor suppressor function is that overexpression of the BRCA1 protein leads to growth suppression similar to that seen with the classic tumor suppressors <related-object link-type="booklink" source-id="gene" document-id="li-fraumeni" document-type="chapter"><italic toggle="yes">TP53</italic></related-object> and the <related-object link-type="booklink" source-id="gene" document-id="retinoblastoma" document-type="chapter">retinoblastoma</related-object> gene (<italic toggle="yes">RB1</italic>) [<xref ref-type="bibr" rid="brca1.REF.holt.1996.298">Holt et al 1996</xref>]. Loss of function of <italic toggle="yes">BRCA1</italic> results in defects in DNA repair, defects in transcription, abnormal centrosome duplication, defective G2/M cell-cycle checkpoint regulation, impaired spindle checkpoint, and chromosome damage [<xref ref-type="bibr" rid="brca1.REF.brodie.2001.s18">Brodie &#x00026; Deng 2001</xref>, <xref ref-type="bibr" rid="brca1.REF.deng.2002.171">Deng 2002</xref>, <xref ref-type="bibr" rid="brca1.REF.venkitaraman.2002.171">Venkitaraman 2002</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">BRCA2</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">BRCA2</italic> encodes a 10.4-kb transcript composed of 27 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="brca1" object-id="brca1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> As with <italic toggle="yes">BRCA1</italic>, more than 1800 pathogenic variants in <italic toggle="yes">BRCA2</italic> have been identified. (For more information, see <related-object source-id="gene" document-id="brca1" object-id="brca1.molgen.TA">Table A</related-object>.) Overall, approximately 2.9% of individuals undergoing molecular genetic testing of <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> will have a variant of uncertain clinical significance [<xref ref-type="bibr" rid="brca1.REF.eggington.2012">Eggington et al 2012</xref>] &#x02013; a proportion that has declined significantly over the past ten years (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://research.nhgri.nih.gov/bic/">NHGRI-BIC Database</ext-link>). In the future, some of these will likely prove to be benign variants without clinical significance, while others may be associated with an increased cancer risk.</p>
        <p><bold>Reduced-penetrance variant.</bold> There is evidence that p.Lys3326Ter is associated with risk of developing breast and ovarian cancers independent of other pathogenic variants in <italic toggle="yes">BRCA2</italic>, although penetrance is reduced. This was demonstrated through a large case-control study based on an international consortium of patients with cancer. Further studies are needed to determine the biologic mechanism of action responsible for these associations [<xref ref-type="bibr" rid="brca1.REF.meeks.2015.djv315">Meeks et al 2015</xref>].</p>
        <table-wrap id="brca1.T.selected_brca2_pathogenic_varian" orientation="portrait" position="anchor">
          <label>Table 5. </label>
          <caption>
            <p>Selected <italic toggle="yes">BRCA2</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.771_775delTCAAA<break/>(999del5)</td>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn257LysfsTer17</td>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/119395733">NM_000059.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/119395734">NP_000050.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5946delT<break/>(6174delT)</td>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser1982ArgfsTer22</td>
              </tr>
              <tr>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.9976A&#x0003e;T</td>
                <td headers="hd_h_brca1.T.selected_brca2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys3326Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="brca1.TF.5.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">BRCA2</italic> encodes a 380-kd protein of 3,418 amino acids. Eight 30-40 residue motifs found in exon 11 mediate the binding of breast cancer type 2 susceptibility protein (BRCA2) to RAD51. BRCA2 is a phosphoprotein normally located in the nucleus [<xref ref-type="bibr" rid="brca1.REF.bertwistle.1997.5485">Bertwistle et al 1997</xref>]. BRCA2 protein has no recognizable protein motifs and no apparent relation to the breast cancer type 1 susceptibility protein.</p>
        <p>Like <italic toggle="yes">BRCA1</italic>, <italic toggle="yes">BRCA2</italic> is expressed in most tissues and cell types analyzed, indicating that gene expression does not account for the tissue-restricted phenotype of breast and ovarian cancer. <italic toggle="yes">BRCA2</italic> transcription is induced late in the G<sub>1</sub> phase of the cell cycle and remains elevated during the S phase, indicating some role in DNA synthesis [<xref ref-type="bibr" rid="brca1.REF.rajan.1996.13078">Rajan et al 1996</xref>, <xref ref-type="bibr" rid="brca1.REF.vaughn.1996.4590">Vaughn et al 1996</xref>].</p>
        <p><italic toggle="yes">BRCA2</italic> appears to be involved in the DNA repair process. The breast cancer type 2 susceptibility protein interacts with the RAD51 protein, a key component in homologous recombination and double-strand break repair [<xref ref-type="bibr" rid="brca1.REF.sharan.1997.804">Sharan et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.wong.1997.31941">Wong et al 1997</xref>]. Through this interaction, BRCA2 regulates the availability and activity of RAD51, which coats single-strand DNA to form a nucleoprotein filament that invades and pairs with a homologous DNA duplex to initiate strand exchange [<xref ref-type="bibr" rid="brca1.REF.venkitaraman.2002.171">Venkitaraman 2002</xref>].</p>
        <p>Complete loss of <italic toggle="yes">Brca2</italic> in the mouse is embryonic lethal, characterized by a lack of cell proliferation [<xref ref-type="bibr" rid="brca1.REF.ludwig.1997.1226">Ludwig et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.sharan.1997.804">Sharan et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.suzuki.1997.1242">Suzuki et al 1997</xref>]. Cells derived from mouse embryos lacking <italic toggle="yes">Brca2</italic> are defective in their repair of DNA damage [<xref ref-type="bibr" rid="brca1.REF.connor.1997.423">Connor et al 1997</xref>, <xref ref-type="bibr" rid="brca1.REF.chen.1998b.5287">Chen et al 1998b</xref>] and are hypersensitive to radiation and radiomimetics [<xref ref-type="bibr" rid="brca1.REF.abbott.1998.978">Abbott et al 1998</xref>, <xref ref-type="bibr" rid="brca1.REF.biggs.1998.951">Biggs &#x00026; Bradley 1998</xref>, <xref ref-type="bibr" rid="brca1.REF.chen.1998a.317">Chen et al 1998a</xref>, <xref ref-type="bibr" rid="brca1.REF.morimatsu.1998.3441">Morimatsu et al 1998</xref>] &#x02013; findings that may have implications for both mammographic screening and treatment modalities. Finally, <italic toggle="yes">Brca2</italic> knockout mice can be partially rescued by crossing with a <italic toggle="yes">Tp53</italic> knockout strain, suggesting that these genes interact with the <italic toggle="yes">TP53</italic> -mediated DNA damage checkpoint [<xref ref-type="bibr" rid="brca1.REF.brugarolas.1997.721">Brugarolas &#x00026; Jacks 1997</xref>]. Therefore, the available evidence indicates that <italic toggle="yes">BRCA2</italic> is a &#x0201c;caretaker,&#x0201d; like <italic toggle="yes">TP53</italic>, serving to maintain genomic integrity [<xref ref-type="bibr" rid="brca1.REF.zhang.1998.433">Zhang et al 1998</xref>]. It is likely that <italic toggle="yes">BRCA2</italic> will eventually be implicated in a variety of cellular processes, only some of which will be related to their role in the etiology of breast and ovarian cancer.</p>
        <p><bold>Abnormal gene product.</bold> Most <italic toggle="yes">BRCA2</italic> pathogenic variants reported to date consist of frameshift deletions, insertions, or nonsense variants that predict premature truncation of protein transcription, consistent with the loss of function that is expected with clinically significant variants of tumor suppressor genes. Cells lacking BRCA2 are deficient in the repair of double-strand DNA breaks, as reflected in a hypersensitivity to ionizing radiation [<xref ref-type="bibr" rid="brca1.REF.venkitaraman.2001.3591">Venkitaraman 2001</xref>].</p>
      </sec>
      <sec id="brca1.References">
        <title>References</title>
        <sec id="brca1.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="brca1.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="brca1.REF1">
              <mixed-citation publication-type="web"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection">NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian</ext-link>). registration or institutional access required. Accessed 12-8-16</mixed-citation>
            </ref>
            <ref id="brca1.REF2">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>; registration or institutional access required. 2010. Accessed 6-16-17</mixed-citation>
            </ref>
            <ref id="brca1.REF3">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 6-16-17.</mixed-citation>
            </ref>
            <ref id="brca1.REF4">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nsgc.org/p/bl/et/blogaid=860">online</ext-link>. 2017. Accessed 6-16-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="brca1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="brca1.Literature_Cited.reflist0">
            <ref id="brca1.REF.abbott.1998.978">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abbott</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>1998</year>
                <volume>90</volume>
                <fpage>978</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">9665145</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.alsop.2012.2654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alsop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fereday</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meldrum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>deFazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmanuel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobrovic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedlander</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowtell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.</article-title>
                <source>J Clin Oncol</source>
                <volume>30</volume>
                <fpage>2654</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">22711857</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.american_society_of_clinical_oncology.2003.2397">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>American Society of Clinical Oncology</collab>
                </person-group>
                <article-title>Policy statement update: genetic testing for cancer susceptibility.</article-title>
                <source>J Clin Oncol.</source>
                <year>2003</year>
                <volume>21</volume>
                <fpage>2397</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">12692171</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.anglian_breast_cancer_study_group.2000.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>Anglian Breast Cancer Study Group</collab>
                </person-group>
                <article-title>Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series ofbreast cancer cases.</article-title>
                <source>Br J Cancer.</source>
                <year>2000</year>
                <volume>83</volume>
                <fpage>1301</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11044354</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.antoniou.2014.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casadei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heikkinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrowdale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pylk&#x000e4;s</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramanian</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Leeneer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fostira</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomiak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teo</surname>
                    <given-names>ZL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aittom&#x000e4;ki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moilanen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannermaa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallioniemi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindeman</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radice</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tondini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoukian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toland</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miron</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzel</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yannoukakos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterlongo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevanlinna</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winqvist</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Breast-cancer risk in families with mutations in PALB2.</article-title>
                <source>N Engl J Med.</source>
                <year>2014</year>
                <volume>371</volume>
                <fpage>497</fpage>
                <lpage>506</lpage>
                <pub-id pub-id-type="pmid">25099575</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.antoniou.2004.1580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pharoah</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The BOADICEA model of genetic susceptibility to breast and ovarian cancer.</article-title>
                <source>Br J Cancer</source>
                <volume>91</volume>
                <fpage>1580</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15381934</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.beiner.2007.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beiner</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2007</year>
                <article-title>The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.</article-title>
                <source>Gynecol Oncol.</source>
                <volume>104</volume>
                <fpage>7</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">16962648</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bernstein.2006.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teraoka</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapinski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolitzer</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the breast cancer family registry.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev</source>
                <volume>15</volume>
                <fpage>348</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16492927</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bertwistle.1997.5485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertwistle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marston</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crompton</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Nuclear location and cell cycle regulation of the BRCA2 protein.</article-title>
                <source>Cancer Res</source>
                <volume>57</volume>
                <fpage>5485</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9407955</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.biggs.1998.951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biggs</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A step toward genotype-based therapeutic regimens for breast cancer in patients with BRCA2 mutations?</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>90</volume>
                <fpage>951</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9665137</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.boddy.1994.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boddy</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freemont</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borden</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger.</article-title>
                <source>Trends Biochem Sci</source>
                <volume>19</volume>
                <fpage>198</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8048160</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bolton.2012.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolton</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chenevix-Trench</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gob</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadetzke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramus</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlan</surname>
                    <given-names>BY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambrechts</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Despierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrowdale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinilnikova</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benetiz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gail</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peock</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godwin</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>EDK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanco</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x02019;Andrea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoletto</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnatty</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jjaer</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogdall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goode</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fridley</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loud</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mai</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chetrit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsh-Yechezkel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glendon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toland</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gore</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michie</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieh</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristoffersson</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beattie</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moysich</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cass</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leuchter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Closas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayther</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanock</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pharoah</surname>
                    <given-names>PDP</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2012</year>
                <article-title>Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.</article-title>
                <source>JAMA</source>
                <volume>307</volume>
                <fpage>382</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">22274685</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bordeleau.2010.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bordeleau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panchal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodwin</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Prognosis of BRCA-associated breast cancer: a summary of evidence.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2010</year>
                <volume>119</volume>
                <fpage>13</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">19789974</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bork.1997.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bork</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bucher</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuwald</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altschul</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koonin</surname>
                    <given-names>EV</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.</article-title>
                <source>FASEB J</source>
                <volume>11</volume>
                <fpage>68</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">9034168</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.breast_cancer_linkage_consortium.1999.1310">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>Breast Cancer Linkage Consortium</collab>
                </person-group>
                <year>1999</year>
                <article-title>Cancer risks in BRCA2 mutation carriers.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>91</volume>
                <fpage>1310</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10433620</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.brodie.2001.s18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brodie</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>CX</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>BRCA1-associated tumorigenesis: what have we learned from knockout mice?</article-title>
                <source>Trends Genet</source>
                <volume>17</volume>
                <fpage>S18</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11585672</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.brookswilson.2004.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brooks-Wilson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaurah</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suriano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grehan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butterfield</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeyes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schinas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacani</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacGillivray</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Australie</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaPointe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilpin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikkel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilchrist</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaghan</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveira</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seruca</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huntsman</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.</article-title>
                <source>J Med Genet.</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>508</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">15235021</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.brugarolas.1997.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brugarolas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacks</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.</article-title>
                <source>Nat Med</source>
                <volume>3</volume>
                <fpage>721</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">9212093</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.bubien.2013.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bubien</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouste</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barouk-Simonet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Layet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caron</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert-Dussardier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delnatte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dugast</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fricker</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevenet</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caux</surname>
                    <given-names>F</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.</article-title>
                <source>J Med Genet.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>255</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23335809</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.callebaut.1997.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Callebaut</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mornon</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.</article-title>
                <source>FEBS Lett</source>
                <volume>400</volume>
                <fpage>25</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9000507</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.casadei.2011.2222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casadei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norquist</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stray</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandell</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamatoyannopoulos</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.</article-title>
                <source>Cancer Res.</source>
                <year>2011</year>
                <volume>71</volume>
                <fpage>2222</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21285249</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.casey.2005.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synder</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bewtra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.</article-title>
                <source>Gynecol Oncol</source>
                <volume>97</volume>
                <fpage>457</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">15863145</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chek2_breast_cancer_casecontrol_consortium.2004.1175">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>CHEK2 Breast Cancer Case-Control Consortium</collab>
                </person-group>
                <article-title>CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2004</year>
                <volume>74</volume>
                <fpage>1175</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15122511</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chen.1998a.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walpita</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazdar</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scully</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.</article-title>
                <source>Mol Cell</source>
                <volume>2</volume>
                <fpage>317</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">9774970</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chen.1998b.5287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>ZD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>95</volume>
                <fpage>5287</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">9560268</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chen.2006.863">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iversen</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friebel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkelstein</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schildkraut</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peshkin</surname>
                    <given-names>BN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leondaridis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerber</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strong</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Euhus</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Characterization of BRCA1 and BRCA2 mutations in a large United States sample.</article-title>
                <source>J Clin Oncol.</source>
                <volume>24</volume>
                <fpage>863</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16484695</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chen.1996.3168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.</article-title>
                <source>Cancer Res.</source>
                <volume>56</volume>
                <fpage>3168</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">8764100</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.chlebowski.2003.3243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chlebowski</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrix</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanick</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gass</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodabough</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilligan</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cyr</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khandekar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrovitch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McTiernan</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.</article-title>
                <source>JAMA</source>
                <volume>289</volume>
                <fpage>3243</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12824205</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.cibula.2011.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cibula</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Widschwendter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majek</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusek</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>tubal ligation and the risk of ovarian cancer: review and meta-analysis.</article-title>
                <source>Hum Reprod Update</source>
                <volume>17</volume>
                <fpage>55</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">20634209</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.connor.1997.423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Connor</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertwistle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mee</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigorieva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tybulewicz</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.</article-title>
                <source>Nat Genet</source>
                <volume>17</volume>
                <fpage>423</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9398843</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.couch.2015.304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toland</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miron</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godwin</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olswold</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slettedahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guidugli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davila</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janni</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rack</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekici</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slamon</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantopoulou</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fostira</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vratimos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fountzilas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelttari</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tapper</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durcan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilarski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapiro</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klemp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambrosone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevanlinna</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yannoukakos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slager</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vachon</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasching</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.</article-title>
                <source>J Clin Oncol.</source>
                <year>2015</year>
                <volume>33</volume>
                <fpage>304</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">25452441</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.cousineau.2005.11384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cousineau</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abaji</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belmaaza</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.</article-title>
                <source>Cancer Res</source>
                <volume>65</volume>
                <fpage>11384</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">16357146</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.daly.2015.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dresher</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeter</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlan</surname>
                    <given-names>BY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alberts</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Salpingectomy as a means to reduce ovarian cancer risk.</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>342</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25586903</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.dann.2012.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dann</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLoia</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timms</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorn</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flake</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanchbury</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirvak</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>BRCA1/2 muatations and expression: resonse to platinum chemogherapy in patients with advanced stage epithelial ovarian cancer.</article-title>
                <source>Gynecol Oncol</source>
                <volume>125</volume>
                <fpage>677</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">22406760</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.de_la_hoya.2003.503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de la Hoya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;ez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Segura</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godino</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiget</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;az-Rubio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cald&#x000e9;s</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.</article-title>
                <source>J Med Genet.</source>
                <year>2003</year>
                <volume>40</volume>
                <fpage>503</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12843322</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.de_leeneer.2012.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Leeneer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coene</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crombez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simkens</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Broecke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bols</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stragier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhoutte</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2012</year>
                <volume>132</volume>
                <fpage>87</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">21553119</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.deng.2006.1416">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>CX</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.</article-title>
                <source>Nucleic Acids Research</source>
                <volume>34</volume>
                <fpage>1416</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">16522651</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.deng.2002.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>CX</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Tumor formation in Brca1 conditional mutant mice.</article-title>
                <source>Environ Mol Mutagen</source>
                <volume>39</volume>
                <fpage>171</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11921186</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.diez.2010.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guti&#x000e9;rrez-Enr&#x000ed;quez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mediano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadea</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balma&#x000f1;a</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2010</year>
                <volume>121</volume>
                <fpage>221</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19649703</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ding.2011.771">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuan</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greilac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2011</year>
                <volume>126</volume>
                <fpage>771</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20927582</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.domchek.2011">
              <mixed-citation publication-type="confproc">Domchek SM, Friebel T, Neuhausen SL, Lynch HT, Singer CF, Eeles RA, Isaacs C, Tung NM, Ganz PA, Couch FJ, Weitzel JN, Olopade OI, Rubinstein WS, Tomlinson GE, Pichert GC, Daly MB, Matloff ET, Evans DG, Garber JE, Rebbeck TR, et al. Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer. Abstract 1501. Chicago, IL: ASCO Annual Meeting; 2011.</mixed-citation>
            </ref>
            <ref id="brca1.REF.easton.1995.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.</article-title>
                <source>Am J Hum Genet</source>
                <volume>56</volume>
                <fpage>265</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">7825587</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.eggington.2012">
              <mixed-citation publication-type="confproc">Eggington JM, Burbidge LA, Roa BB, Pruss D, Bowles K, Rosenthal E, Wenstrup R. Current variant of uncertain significance rates in BRCA1/2 and Lynch syndrome testing (MLH1, MSH2, MSH6, PMS2, EPCAM). Poster. Charlotte, NC: American College of Medical Genetics Annual Clinical Genetics Meeting. 2012.</mixed-citation>
            </ref>
            <ref id="brca1.REF.eisen.2008.1361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronwald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klijn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim-Sing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoukian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rennert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2008</year>
                <article-title>Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.</article-title>
                <source>J Natl Cancer Inst.</source>
                <volume>100</volume>
                <fpage>1361</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18812548</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.euhus.2002.844">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Euhus</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chittenden</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieger</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esserman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roche</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seldon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabian</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klemp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2002</year>
                <volume>94</volume>
                <fpage>844</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12048272</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.evans.2004.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amir</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shenton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.</article-title>
                <source>J Med Genet.</source>
                <volume>41</volume>
                <fpage>474</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15173236</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.evans.2011.520">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer.</article-title>
                <source>J Med Genet.</source>
                <year>2011</year>
                <volume>48</volume>
                <fpage>520</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">21653198</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.evans.2010.710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susnerwala</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Risk of breast cancer in male BRCA2 carriers.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>710</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">20587410</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ewald.2009.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ewald</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmero</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossio</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giugliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton-Prolla</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Genomic rearrangements in BRCA1 and BRCA2: A literature review.</article-title>
                <source>Genet Mol Biol.</source>
                <year>2009</year>
                <volume>32</volume>
                <fpage>437</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">21637503</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ferla.2007.vi93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferla</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cal&#x000f2;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badalamenti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carreca</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surmacz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colucci</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bazan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Founder mutations in BRCA1 and BRCA2 genes.</article-title>
                <source>Ann Oncol.</source>
                <volume>18</volume>
                <supplement>Suppl 6</supplement>
                <fpage>vi93</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17591843</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ferrone.2009.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrone</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarnagin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brennan</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.</article-title>
                <source>J Clin Oncol.</source>
                <volume>27</volume>
                <fpage>433</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19064968</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ford.1994.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <article-title>Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.</article-title>
                <source>Lancet.</source>
                <year>1994</year>
                <volume>343</volume>
                <fpage>692</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7907678</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ford.1998.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenoir</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang-Claude</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobol</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teare</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Struewing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arason</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherneck</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkardottir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyfjord</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponder</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayther</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelada-Hedman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1998</year>
                <volume>62</volume>
                <fpage>676</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">9497246</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.frank.2002.1480">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frank</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deffenbaugh</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lingenfelter</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gumpper</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavtigian</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruss</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Critchfield</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.</article-title>
                <source>J Clin Oncol</source>
                <volume>20</volume>
                <fpage>1480</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11896095</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.friebel.2014.dju091">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friebel</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                </person-group>
                <article-title>Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2014</year>
                <volume>106</volume>
                <fpage>dju091</fpage>
                <pub-id pub-id-type="pmid">24824314</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.fujiwara.2012.1170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieh</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longacre</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria, identification of a BRCA1 ovarian cancer phenotype.</article-title>
                <source>Am J Surg Pathol</source>
                <volume>36</volume>
                <fpage>1170</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22790858</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.gallagher.2010.2115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallagher</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudet</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirchhoff</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balistreri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vora</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stadler</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reuter</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelefsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scher</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eastham</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scardino</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>2115</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">20215531</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.garciacasado.2011.134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Casado</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Serra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llopis</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llombart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Guerrero</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer.</article-title>
                <source>BMC Med Genet.</source>
                <year>2011</year>
                <volume>12</volume>
                <fpage>134</fpage>
                <pub-id pub-id-type="pmid">21989022</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.goldgar.2011.r73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowty</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Da Silva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terry</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>BCFR; kConFab, Khanna KK, Hopper JL, Oefner PJ, Lakhani S, Chenevix-Trench G. Rare variants in the ATM gene and risk of breast cancer.</article-title>
                <source>Breast Cancer Res.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>R73</fpage>
                <pub-id pub-id-type="pmid">21787400</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.goshen.2000.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goshen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elit</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakimi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fyles</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?</article-title>
                <source>Gynecol Oncol.</source>
                <year>2000</year>
                <volume>79</volume>
                <fpage>477</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11104623</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.gowen.1998.1009">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gowen</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avrutskaya</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latour</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koller</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leadon</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>BRCA1 required for transcription-coupled repair of oxidative DNA damage.</article-title>
                <source>Science.</source>
                <year>1998</year>
                <volume>281</volume>
                <fpage>1009</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9703501</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.graeser.2009.5887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graeser</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhiem</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadzicki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bick</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kast</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froster</surname>
                    <given-names>UG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlehe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bechtold</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preisler-Adams</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nestle-Kraemling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeffler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiechle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varga</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmutzler</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>J Clin Oncol.</source>
                <year>2009</year>
                <volume>27</volume>
                <fpage>5887</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19858402</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.gruber.2002.1344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cancer risks in BRCA1 carriers: time for the next generation of studies.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>94</volume>
                <fpage>1344</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12237273</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.gudas.1996.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gudas</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauscher</surname>
                    <given-names>FJ</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.</article-title>
                <source>Cell Growth Differ</source>
                <volume>7</volume>
                <fpage>717</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">8780885</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.haffty.2002.1471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haffty</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pathare</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glazer</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matloff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez-Franco</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.</article-title>
                <source>Lancet.</source>
                <year>2002</year>
                <volume>359</volume>
                <fpage>1471</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11988246</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.hakem.1996.1009">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakem</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Pompa</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakeham</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reitmair</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firpo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossant</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.</article-title>
                <source>Cell</source>
                <volume>85</volume>
                <fpage>1009</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">8674108</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.hansen.2008.58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgaard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f8;nson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrechtsen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filtenborg-Barnkob</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eiberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ejlertsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>FC</given-names>
                  </name>
                </person-group>
                <article-title>Novel de novo BRCA2 mutation in a patient with a family history of breast cancer.</article-title>
                <source>BMC Med Genet.</source>
                <year>2008</year>
                <volume>9</volume>
                <fpage>58</fpage>
                <pub-id pub-id-type="pmid">18597679</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.hearle.2003.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hearle</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damato</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humphreys</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wixey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlston</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2003</year>
                <volume>44</volume>
                <fpage>458</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">12556369</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.hobert.2009.687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobert</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>PTEN hamartoma tumor syndrome: an overview.</article-title>
                <source>Genet Med.</source>
                <year>2009</year>
                <volume>11</volume>
                <fpage>687</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">19668082</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.holt.1996.298">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson-Benion</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arteaga</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Growth retardation and tumour inhibition by BRCA1.</article-title>
                <source>Nat Genet</source>
                <volume>12</volume>
                <fpage>298</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">8589721</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.howlett.2002.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howlett</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Die-Smulders</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persky</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Biallelic inactivation of BRCA2 in Fanconi anemia.</article-title>
                <source>Science</source>
                <volume>297</volume>
                <fpage>606</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12065746</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.iqbal.2012.2005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iqbal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ainsworth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim-Sing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llacuachaqui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ping</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>Br J Cancer.</source>
                <year>2012</year>
                <volume>107</volume>
                <fpage>2005</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23099806</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.jernstr_m.2004.1094">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jernstr&#x000f6;m</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershoni-Baruch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ainsworth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>96</volume>
                <fpage>1094</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15265971</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.jones.2009.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruban</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borges</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmisano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brune</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaffee</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobuzio-Donahue</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maitra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velculescu</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshleman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goggins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.</article-title>
                <source>Science.</source>
                <year>2009</year>
                <volume>324</volume>
                <fpage>217</fpage>
                <pub-id pub-id-type="pmid">19264984</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.judkins.2012.5210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Judkins</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burbidge</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geary</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrus</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoenberger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trost</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenstrup</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roa</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <article-title>Clinical significance of large rearrangements in BRCA1 and BRCA2.</article-title>
                <source>Cancer.</source>
                <year>2012</year>
                <volume>118</volume>
                <fpage>5210</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22544547</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kang.2010.579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariapun</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phuah</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thong</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohd Taib</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yip</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teo</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2010</year>
                <volume>124</volume>
                <fpage>579</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">20617377</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kauff.2002.1609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kauff</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheuer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hensley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgen</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barakat</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.</article-title>
                <source>N Engl J Med</source>
                <volume>346</volume>
                <fpage>1609</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">12023992</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kaurah.2007.2360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaurah</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chun</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suriano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaor</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Manen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilpin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikkel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly-Wilson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebold</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroop</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yim</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panzini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKinnon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenblatt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirtzfeld</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coit</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauwers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzuti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaccaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redal</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveira</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olschwang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pharoah</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huntsman</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.</article-title>
                <source>JAMA</source>
                <year>2007</year>
                <volume>297</volume>
                <fpage>2360</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17545690</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ketabi.2011.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ketabi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartuma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malander</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorck</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holck</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilbert</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors.</article-title>
                <source>Gynecol Oncol</source>
                <volume>121</volume>
                <fpage>462</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21388660</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.king.2003.643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandell</surname>
                    <given-names>JB</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2003</year>
                <article-title>Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.</article-title>
                <source>Science.</source>
                <volume>302</volume>
                <fpage>643</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14576434</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.king.2001.2251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hale</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tait</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costantino</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wickerham</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolmark</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>B</given-names>
                  </name>
                  <collab>National Surgical Adjuvant Breast and Bowel Project</collab>
                </person-group>
                <year>2001</year>
                <article-title>Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.</article-title>
                <source>JAMA</source>
                <volume>286</volume>
                <fpage>2251</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11710890</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kirova.2005.2304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirova</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savignoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigal-Zafrani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabre</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fourquet</surname>
                    <given-names>A</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.</article-title>
                <source>Eur J Cancer.</source>
                <year>2005</year>
                <volume>41</volume>
                <fpage>2304</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16140006</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kotejarai.2011.1230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kote-Jarai</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leongamornlert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tymrakiewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahmud</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dadaev</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collaborators</surname>
                    <given-names>UKGPCS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.</article-title>
                <source>Br J Cancer.</source>
                <year>2011</year>
                <volume>105</volume>
                <fpage>1230</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21952622</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kotsopoulos.2016.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kotsopoulos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huzarski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronwald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demsky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.</article-title>
                <source>Breast Cancer Res Treat.</source>
                <year>2016</year>
                <volume>155</volume>
                <fpage>365</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">26780555</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.kwong.2011.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kwong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>To</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer.</article-title>
                <source>Fam Cancer.</source>
                <year>2011</year>
                <volume>10</volume>
                <fpage>233</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21404118</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.lauper.2013.e59709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lauper</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaughan</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnat</surname>
                    <given-names>RJ</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Spectrum and risk of neoplasia in Werner syndrome: a systematic review.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e59709</fpage>
                <pub-id pub-id-type="pmid">23573208</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.lee.2011.4373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKean-Cowdin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spicer</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Berg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ursin</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.</article-title>
                <source>J Clin Oncol.</source>
                <year>2011</year>
                <volume>29</volume>
                <fpage>4373</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">22010008</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.leongamornlert.2012.1697">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leongamornlert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahmud</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tymrakiewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dadaev</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Govindasami</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collaborators</surname>
                    <given-names>UKGPCS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kote-Jarai</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Germline BRCA1 mutations increase prostate cancer risk.</article-title>
                <source>Br J Cancer.</source>
                <year>2012</year>
                <volume>106</volume>
                <fpage>1697</fpage>
                <lpage>701</lpage>
                <pub-id pub-id-type="pmid">22516946</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.lubinski.2004.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phelan</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cancer variation associated with the position of the mutation in the BRCA2 gene.</article-title>
                <source>Fam Cancer</source>
                <volume>3</volume>
                <fpage>1</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15131399</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ludwig.1997.1226">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papaioannou</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Efstratiadis</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.</article-title>
                <source>Genes Dev</source>
                <volume>11</volume>
                <fpage>1226</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9171368</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.malone.2010.2404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malone</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begg</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tellhed</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teraoka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capanu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiner</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riedel</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellemkjaer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boice</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anton-Culver</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.</article-title>
                <source>J Clin Oncol</source>
                <volume>28</volume>
                <fpage>2404</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20368571</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.marshall.2009.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence Wickerham</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer.</article-title>
                <source>Clin Genet.</source>
                <year>2009</year>
                <volume>76</volume>
                <fpage>427</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">19796187</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.mavaddat.2013.812">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mavaddat</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peock</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platte</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fineberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adlard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Side</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houghton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaldson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miedzybrodzka</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eason</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barwell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2013</year>
                <volume>105</volume>
                <fpage>812</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">23628597</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.mclaughlin.2013.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLaughlin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moody</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sellers</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2013</year>
                <volume>105</volume>
                <fpage>141</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23257159</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.meeks.2015.djv315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meeks</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michailidou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolla</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrowdale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesoriero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruinsma</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>IG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broeks</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckman</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasching</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riboli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menon</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burwinkel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marme</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolph</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janavicius</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tihomirova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cramer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terry</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tworoger</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorfling</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rensburg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godwin</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu&#x000e9;nel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truong</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiola</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazoyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinilnikova</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maugard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojesen</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flyger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerdes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaer</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogdall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogdall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomassen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Neira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoya Mde</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segura</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anton-Culver</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunjung</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castillo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzel</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlan</surname>
                    <given-names>BY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lester</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayther</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramus</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieh</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittermore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phelan</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terry</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piedmonte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moysich</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannioto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathanson</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrant</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ness</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modugno</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butterbach</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wappenschmidt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000fc;ning</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blomqvist</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevanlinna</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelttari</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aittom&#x000e4;ki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butzow</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogdanova</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000f6;rk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rantala</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosma</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannermaa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambrechts</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neven</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maerken</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang-Claude</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flesch-Janys</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heitz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon-Mateeva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterlongo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radice</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barile</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peissel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoukian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peixoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teixeira</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collavoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goode</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimelis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giles</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milne</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haiman</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soucy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borresen-Dale</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristensen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvesen</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorge</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandera</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeghly-Fadiel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pylk&#x000e4;s</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tollenaar</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouweland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winqvist</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mai</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loud</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Closas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoemaker</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czene</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darabi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNeish</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddiquil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glasspool</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teo</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woo</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foretova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rappaport-Feurhauser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laitman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rennert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imyanitov</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulick</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olah</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schildkraut</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koppert</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiemeney</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massuger</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pejovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d6;fverholm</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossing</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wentzensen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henriksson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabisch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakubowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronwald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agnarsson</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupryjanczyk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moes-Sosnowska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fostira</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantopoulou</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slager</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berchuck</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swerdlow</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chenevix-Trench</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunning</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pharoah</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2015</year>
                <volume>108</volume>
                <fpage>djv315</fpage>
                <pub-id pub-id-type="pmid">26586665</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.metcalfe.2011a.1384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim-Sing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLennan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2011a</year>
                <article-title>Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>Br J Cancer</source>
                <volume>104</volume>
                <fpage>1384</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">21487411</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.metcalfe.2011b.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim-Sing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vesprini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2011b</year>
                <article-title>Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>Breast Cancer Res Treat</source>
                <volume>127</volume>
                <fpage>287</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">21221768</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.metcalfe.2005.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivotto</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLennan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.</article-title>
                <source>Gynecol Oncol</source>
                <volume>96</volume>
                <fpage>222</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15589605</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.meyer.2012.e38361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landgraf</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;gel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eiermann</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ataseven</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>BRCA2 mutations and triple-negative breast cancer.</article-title>
                <source>PLoS One.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>e38361</fpage>
                <pub-id pub-id-type="pmid">22666503</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.miki.1994.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swensen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shattuck-Eidens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futreal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harshman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavtigian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cochran</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McClure</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frye</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phelps</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haugen-Strano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katcher</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yakumo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gholami</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wray</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogden</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dayananth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brostow</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norris</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helvering</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosteck</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon-Albright</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiseman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skolnik</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.</article-title>
                <source>Science</source>
                <volume>266</volume>
                <fpage>66</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">7545954</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.mocci.2013.803">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mocci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milne</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;ndez-Villamil</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalats</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Risk of pancreatic cacner in breast cancer families form the breast cancer family registry.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev</source>
                <volume>22</volume>
                <fpage>803</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">23456555</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.moran.2012.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shack</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <article-title>Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.</article-title>
                <source>Fam Cancer.</source>
                <year>2012</year>
                <volume>11</volume>
                <fpage>235</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">22187320</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.morimatsu.1998.3441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morimatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donoho</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasty</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence.</article-title>
                <source>Cancer Res</source>
                <volume>58</volume>
                <fpage>3441</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9699678</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.m_ller.2002.1014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edmonston</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corao</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palazzo</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fry</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rueschoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishel</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Cancer Res.</source>
                <year>2002</year>
                <volume>62</volume>
                <fpage>1014</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11861375</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.narod.2000.1876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadirian</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimdal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de los Rios</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2000</year>
                <article-title>Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.</article-title>
                <source>Lancet</source>
                <volume>356</volume>
                <fpage>1876</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11130383</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.n_slundkoch.2016.1208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>N&#x000e4;slund-Koch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordestgaard</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojesen</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Increased risk for other cancers in addition to breast cancer for CHEK2*1100delC heterozygotes estimated from the Copenhagen General Population Study.</article-title>
                <source>J Clin Oncol.</source>
                <year>2016</year>
                <volume>34</volume>
                <fpage>1208</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">26884562</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ngeow.2014.1818">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ngeow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanuch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mester</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnholtz-Sloan</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.</article-title>
                <source>J Clin Oncol.</source>
                <year>2014</year>
                <volume>32</volume>
                <fpage>1818</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">24778394</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.niell.2004.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niell</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rennert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonner</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almog</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomsho</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer.</article-title>
                <source>J Natl Cancer Inst</source>
                <year>2004</year>
                <volume>96</volume>
                <fpage>15</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">14709734</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.nieuwenhuis.2014.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nieuwenhuis</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kets</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy-Ryan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;ller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olderode-Berends</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aretz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinimann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez Garc&#x000ed;a</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spigelman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timshel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                </person-group>
                <article-title>Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.</article-title>
                <source>Fam Cancer.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>57</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23934601</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ouchi.1998.2302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ouchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>August</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaronson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanafusa</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>BRCA1 regulates p53- dependent gene expression.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>95</volume>
                <fpage>2302</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9482880</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.palma.2008.7006">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palma</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stopfer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlichman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegfried</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tigges-Cardwell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathanson</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <article-title>The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.</article-title>
                <source>Cancer Res.</source>
                <year>2008</year>
                <volume>68</volume>
                <fpage>7006</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">18703817</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.parmigiani.1998.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguilar</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>145</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">9443863</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.pierce.2010.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierce</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaffney</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haffty</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-David</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merajver</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balmana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meirovitz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.</article-title>
                <source>Breast Cancer Res Treat</source>
                <volume>121</volume>
                <fpage>389</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">20411323</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rajan.1996.13078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajan</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquis</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chodosh</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1996</year>
                <volume>93</volume>
                <fpage>13078</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">8917547</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rakha.2008.2568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rakha</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis-Filho</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>IO</given-names>
                  </name>
                </person-group>
                <article-title>Basal-like breast cancer: a critical review.</article-title>
                <source>J Clin Oncol.</source>
                <year>2008</year>
                <volume>26</volume>
                <fpage>2568</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18487574</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rebbeck.2005.7804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friebel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van 't Veer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matloff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2005</year>
                <article-title>Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.</article-title>
                <source>J Clin Oncol</source>
                <volume>23</volume>
                <fpage>7804</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">16219936</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rebbeck.2002.1616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van't Veer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matloff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.</article-title>
                <source>N Engl J Med</source>
                <volume>346</volume>
                <fpage>1616</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">12023993</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rebbeck.2015.1347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rebbeck</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitra</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinilnikova</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazoyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chenevix-Trench</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathanson</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laitman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushnir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paluch-Shimon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zidan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehrencrona</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenmark-Askmalm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Einbeigi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbst</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rantala</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seldon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganz</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odunsi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayther</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arun</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlan</surname>
                    <given-names>BY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lester</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godwin</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pathak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terry</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janavicius</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tihomirova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorfling</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rensburg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuhausen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ejlertsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerdes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000f3;n y Cajal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godino</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tejada</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzel</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobolis</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sand</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peissel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonanni</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaffaroni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vignolo-Lutati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scuvera</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genuardi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radice</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolcetti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoukian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pensotti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gismondi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yannoukakos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fostira</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashid</surname>
                    <given-names>MU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peock</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platte</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adlard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaldson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmutzler</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wappenschmidt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhiem</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ditsch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plendl</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundhenke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niederacher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleisch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutter</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartram</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dikow</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang-Gohrke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadzicki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinemann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kast</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon-Mateeva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehrig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinilnikova</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazoyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houdayer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belotti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier-Villars</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiola</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutry-Kryza</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasset</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobol</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peyrat</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fricker</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collonge-Rame</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortemousque</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nogues</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Leeneer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piedmonte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakely</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggess</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blank</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basil</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azodi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldes</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Hoya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevanlinna</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aittom&#x000e4;ki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hout</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoef</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coll&#x000e9;e</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seynaeve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterwijk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez Garcia</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kets</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aalfs</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensenkamp</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olah</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanco</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salinas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakubowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronwald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaworska-Bieniek</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sukiennicki</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huzarski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cybulski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toloczko-Grabarek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x00142;owocka-Per&#x00142;owska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menkiszak</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arason</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkardottir</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laframboise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alducci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peixoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teixeira</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friebel</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guidugli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foretova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rau-Murthy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauff</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink-Retter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rappaport</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gschwantler-Kaulich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiler</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tea</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mai</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imyanitov</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toland</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojesen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skytte</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunde</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomassen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeller</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruse</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caligo</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aretini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teo</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selkirk</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulick</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>I</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.</article-title>
                <source>JAMA</source>
                <year>2015</year>
                <volume>313</volume>
                <fpage>1347</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">25849179</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.renwick.2006.873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renwick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chagtai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayatilake</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barfoot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratton</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2006</year>
                <article-title>ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>873</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16832357</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.risch.2006.1694">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLaughlin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.</article-title>
                <source>J Natl Cancer Inst.</source>
                <volume>98</volume>
                <fpage>1694</fpage>
                <lpage>706</lpage>
                <pub-id pub-id-type="pmid">17148771</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.roberts.2012.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopelovich</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondy</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cote</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axilbund</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulick</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>SZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshleman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velculescu</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goggins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadopoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruban</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>ATM mutations in patients with hereditary pancreatic cancer.</article-title>
                <source>Cancer Discov.</source>
                <year>2012</year>
                <volume>2</volume>
                <fpage>41</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22585167</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.robson.1998.1642">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilewski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirschaut</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pressman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesser</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>BRCA-associated breast cancer in young women.</article-title>
                <source>J Clin Oncol.</source>
                <year>1998</year>
                <volume>16</volume>
                <fpage>1642</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9586873</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.robson.2005.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svahn</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.</article-title>
                <source>Cancer.</source>
                <year>2005</year>
                <volume>103</volume>
                <fpage>44</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15558796</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.robson.2004.r8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chappuis</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goffin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberge</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;gin</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.</article-title>
                <source>Breast Cancer Res.</source>
                <volume>6</volume>
                <fpage>R8</fpage>
                <lpage>R17</lpage>
                <pub-id pub-id-type="pmid">14680495</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rosen.2006.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>BRCA1 regulation of transcription.</article-title>
                <source>Cancer Lett</source>
                <volume>236</volume>
                <fpage>175</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15975711</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.ruijs.2010.421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruijs</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoef</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rookus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruntel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hout</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aalfs</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Asperen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez Garcia</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ten Kate</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van't Veer</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <article-title>TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>421</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20522432</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.rutter.2003.1072">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rutter</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wacholder</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chetrit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menczer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebbers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Struewing</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartge</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.</article-title>
                <source>J Natl Cancer Inst.</source>
                <volume>95</volume>
                <fpage>1072</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12865453</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.sankaran.2006.4100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sankaran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starita</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvin</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.</article-title>
                <source>Cancer Res</source>
                <volume>66</volume>
                <fpage>4100</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16618730</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.satagopan.2002.3776">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauff</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheuer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Ovarian cancer risk in Ashkenazi Jewish carrier of BRCA1 and BRCA2 mutations.</article-title>
                <source>Clin Cancer Res</source>
                <volume>8</volume>
                <fpage>3776</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12473589</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.satagopan.2001.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wacholder</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karp</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begg</surname>
                    <given-names>CB</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev</source>
                <volume>10</volume>
                <fpage>467</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">11352856</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.seynaeve.2004.1150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seynaeve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoog</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Bosch</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Geel</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menke-Pluymers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ouweland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creutzberg</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niermeijer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klijn</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brekelmans</surname>
                    <given-names>CT</given-names>
                  </name>
                </person-group>
                <article-title>Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.</article-title>
                <source>Eur J Cancer.</source>
                <year>2004</year>
                <volume>40</volume>
                <fpage>1150</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15110878</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.sharan.1997.804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharan</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sands</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasty</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.</article-title>
                <source>Nature</source>
                <volume>386</volume>
                <fpage>804</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9126738</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.slater.2010.490">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Slater</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemczyk</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habbe</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neoptolemos</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenhalf</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>DK</given-names>
                  </name>
                </person-group>
                <article-title>PALB2 mutations in European familial pancreatic cancer families.</article-title>
                <source>Clin Genet.</source>
                <year>2010</year>
                <volume>78</volume>
                <fpage>490</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20412113</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.smith.1992.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponder</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.</article-title>
                <source>Nat Genet</source>
                <volume>2</volume>
                <fpage>128</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">1303261</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.somasundaram.1997.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Somasundaram</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>YX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houvras</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licht</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Deiry</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.</article-title>
                <source>Nature</source>
                <volume>389</volume>
                <fpage>187</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9296497</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.spurdle.2012.525">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiley</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pettigrew</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Asperen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kattentidt-Mouravieva</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ouweland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pigg</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmutzler</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinilnikova</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lidereau</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guidugli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomassen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toland</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Rensburg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wappenschmidt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>&#x000c5;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vreeswijk</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldgar</surname>
                    <given-names>DE</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.</article-title>
                <source>J Med Genet.</source>
                <year>2012</year>
                <volume>49</volume>
                <fpage>525</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">22889855</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.stecklein.2012.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stecklein</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.</article-title>
                <source>Transl Res.</source>
                <volume>160</volume>
                <fpage>178</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">22683426</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.suzuki.1997.1242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Pompa</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakem</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishina</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakeham</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koo</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billia</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Brca2 is required for embryonic cellular proliferation in the mouse.</article-title>
                <source>Genes Dev</source>
                <volume>11</volume>
                <fpage>1242</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">9171369</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.tai.2007.1811">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tai</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domchek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>99</volume>
                <fpage>1811</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18042939</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.tan.2012.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mester</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ngeow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rybicki</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orloff</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Lifetime cancer risks in individuals with germline PTEN mutations.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2012</year>
                <volume>18</volume>
                <fpage>400</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22252256</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.tavtigian.2009.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tavtigian</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oefner</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babikyan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Calvez-Kelm</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesueur</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrnes</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuang</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forey</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feuchtinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gioia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashibe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herte</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKay-Chopin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vall&#x000e9;e</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voegele</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteman</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sangrajrang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chenevix-Trench</surname>
                    <given-names>G</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2009</year>
                <volume>85</volume>
                <fpage>427</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">19781682</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.templeton.2016.e0154789">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Templeton</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vera-Badillo</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tibau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x00160;eruga</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srikanthan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandiella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amir</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ocana</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Interaction between hormonal receptor status, age and survival in patients with BRCA1/2 germline mutations: a systematic review and meta-regression.</article-title>
                <source>PLoS One.</source>
                <year>2016</year>
                <volume>11</volume>
                <fpage>e0154789</fpage>
                <pub-id pub-id-type="pmid">27149669</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.thompson.2001.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2001</year>
                <volume>68</volume>
                <fpage>410</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11170890</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.thompson.2002.1358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Easton</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The breast cancer linkage consortium. Cancer incidence in BRCA1 mutation carriers.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>94</volume>
                <fpage>1358</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">12237281</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.thorne.2011.1002">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thorne</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedermayr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoh</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clouston</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolton</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2011</year>
                <volume>4</volume>
                <fpage>1002</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">21733824</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.tyrer.2004.1111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tyrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duffy</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuzick</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A breast cancer prediction model incorporating familial and personal risk factors.</article-title>
                <source>Stat Med</source>
                <volume>23</volume>
                <fpage>1111</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15057881</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.van_asperen.2005.711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Asperen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brohet</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoef</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez Garcia</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klijn</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Houwelingen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van't Veer</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rookus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>FE</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2005</year>
                <article-title>Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>711</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16141007</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.van_den_broek.2015.e0120189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van den Broek</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van 't Veer</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tollenaar</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>FE</given-names>
                  </name>
                </person-group>
                <article-title>Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.</article-title>
                <source>PLoS One.</source>
                <year>2015</year>
                <volume>10</volume>
                <fpage>e0120189</fpage>
                <pub-id pub-id-type="pmid">25816289</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.van_der_kolk.2010.643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Kolk</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bock</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leegte</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaapveld</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mourits</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hout</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterwijk</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.</article-title>
                <source>Breast Cancer Res Treat</source>
                <volume>124</volume>
                <fpage>643</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">20204502</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.vaughn.1996.4590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaughn</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirisano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huper</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berchuck</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futreal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iglehart</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Cell cycle control of BRCA2.</article-title>
                <source>Cancer Res</source>
                <volume>56</volume>
                <fpage>4590</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8840967</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.venkitaraman.2001.3591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Venkitaraman</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Functions of BRCA1 and BRCA2 in the biological response to DNA damage.</article-title>
                <source>J Cell Sci</source>
                <volume>114</volume>
                <fpage>3591</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11707511</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.venkitaraman.2002.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Venkitaraman</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cancer susceptibility and the functions of BRCA1 and BRCA2.</article-title>
                <source>Cell</source>
                <volume>108</volume>
                <fpage>171</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11832208</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.verhoog.2000.119s">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verhoog</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berns</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brekelmans</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seynaeve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klijn</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.</article-title>
                <source>J Clin Oncol.</source>
                <year>2000</year>
                <volume>18</volume>
                <fpage>119S</fpage>
                <lpage>24S</lpage>
                <pub-id pub-id-type="pmid">11060339</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.vichapat.2012.3478">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vichapat</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garmo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmqusit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liljegren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llambe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fornander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adolfsson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luchtenborg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.</article-title>
                <source>J Clin Oncol</source>
                <volume>30</volume>
                <fpage>3478</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">22927521</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.walsh.2010.2214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walters</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeone</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suthers</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelzer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gattas</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bapat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuckin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.</article-title>
                <source>Clin Cancer Res.</source>
                <volume>16</volume>
                <fpage>2214</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">20215533</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.weischer.2007.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weischer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojesen</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tybjaerg-Hansen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelsson</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordestgaard</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Increased risk of breast cancer associated with CHEK2*1100delC.</article-title>
                <source>J Clin Oncol.</source>
                <volume>25</volume>
                <fpage>57</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16880452</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.whittemore.2004a.1911">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balise</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pharoah</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dicioccio</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oakley-Girvan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramus</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Usinowicz</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garlinghouse-Jones</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponder</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrulis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piver</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.</article-title>
                <source>Br J Cancer</source>
                <volume>91</volume>
                <fpage>1911</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15545966</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.whittemore.2004b.2078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whittemore</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostrow</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dicioccio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of BRCA1 mutation carriers among U.S.non-Hispanic Whites.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev.</source>
                <year>2004b</year>
                <volume>13</volume>
                <fpage>2078</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15598764</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.wong.1997.31941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>AKC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ormonde</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavtigian</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartel</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.</article-title>
                <source>J Biol Chem</source>
                <volume>272</volume>
                <fpage>31941</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9405383</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.yates.2011.463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deavers</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeler</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mok</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershenson</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2011</year>
                <volume>4</volume>
                <fpage>463</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">21278312</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.zhang.1998.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tombline</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>BRCA1, BRCA2, and DNA damage response: collision or collusion?</article-title>
                <source>Cell</source>
                <volume>92</volume>
                <fpage>433</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9491884</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.zhang.2011.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleischut</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohut</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stadler</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauff</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>80</volume>
                <fpage>97</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21649643</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.zhong.2015.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <article-title>Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2015</year>
                <volume>21</volume>
                <fpage>211</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">25348513</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="brca1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="brca1.Suggested_Reading.reflist0">
            <ref id="brca1.REF.boughey.2010.3591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boughey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Degnim</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vierkant</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.</article-title>
                <source>J Clin Oncol.</source>
                <volume>28</volume>
                <fpage>3591</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20606088</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.garber.2005.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hereditary cancer predisposition syndromes.</article-title>
                <source>J Clin Oncol</source>
                <volume>23</volume>
                <fpage>276</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">15637391</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF.narod.2005.1656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Prevention and management of hereditary breast cancer.</article-title>
                <source>J Clin Oncol</source>
                <volume>23</volume>
                <fpage>1656</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">15755973</pub-id>
              </element-citation>
            </ref>
            <ref id="brca1.REF171">
              <mixed-citation publication-type="web">National Cancer Institute. Genetics of breast and gynecologic cancers (PDQ<sup>&#x000ae;</sup>). Bethesda, MD: National Cancer Institute. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq">online</ext-link>. 2013. Accessed 6-16-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="brca1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="brca1.Author_History">
          <title>Author History</title>
          <p>Julie O Bars Culver, MS; Fred Hutchinson Cancer Research Center (1998-2011) Wylie Burke, MD, PhD; University of Washington (1998-2005) Mary B Daly, MD, PhD (1998-present) Gerald L Feldman, MD, PhD; Wayne State University School of Medicine (2002-2016) Judith L Hull, MS; Memorial Sloan-Kettering Cancer Center (1998-2005) Ephrat Levy-Lahad, MD; Sharre Zedek Medical Center (1998-2007) Tuya Pal, MD (2016-present)Nancie Petrucelli, MS (2002-present)</p>
        </sec>
        <sec id="brca1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 December 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 January 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 June 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 December 2005 (cd) Revision: Differential Diagnosis</p>
            </list-item>
            <list-item>
              <p>3 September 2004 (jbc) Revision: Genetically Related Disorders</p>
            </list-item>
            <list-item>
              <p>29 March 2004 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 March 2000 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 September 1998 (pb) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>January 1998 (jbc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
